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Abstract 
 
Background: Intensive insulin regimens place great demands on caregivers of children 
with type 1 Diabetes (T1D). Challenges associated with caring for a child with T1D can 
impact parental health, quality of life (QoL) and glycaemic control. Although insulin pump 
use is rapidly increasing, there have been no qualitative reviews conducted to synthesise 
studies of parents’ views about the insulin pump. 
Objectives: To explore and synthesise qualitative studies of parents’ views of using the 
insulin pump to manage their child's T1D. 
Method: Systematic searches of Embase, Medline, Cochrane, CINAHL, and PsycINFO 
were conducted. This search was augmented by hand searching selected journals, 
reference lists and Google Scholar. Seven articles from six studies met inclusion criteria. 
Quality assessments were completed using the Critical Appraisal Skills Programme 
criteria. Synthesis was completed using the meta-ethnographic method. 
Results: All of the included studies were of “acceptable” standard or above. Five themes 
common to the included articles were identified: adjusting to the pump; concerns 
regarding child wearing the pump; freedom and flexibility; responsibility sharing; and 
support for the pump. 
Conclusions: Although parents face challenges and experience anxiety in certain areas 
of pump therapy (carbohydrate counting, cannula changes, the constancy of the pump), 
these challenges are commonly accepted for the increased freedom and flexibility offered 
by the pump. Further studies aimed at understanding parents’ experiences of caring for a 
child with T1D using the insulin pump at different developmental stages would support 
tailored guidance for parents at each stage. 
 
Key Words 
Qualitative Research; Meta-ethnography; Parents’ Perspectives; Diabetes Mellitus; Insulin 
Pump 
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Introduction 
 
T1D is one of the most common chronic childhood illnesses1. The number of children 
under 15 years diagnosed with T1D in Europe has been increasing, with incidence rates 
trebling over the last 30 years. Those under 5 have the largest relative increase in T1D. If 
current trends continue, it has been predicted that between 2005 and 2020 prevalent 
cases younger than 15 years will rise by 70%, with incidence rates for those under 5 
doubling2. 
  
Following a diagnosis of T1D, the patient may be expected to integrate intensive insulin 
regimens into their daily routine.  The treatment regimen for T1D may be demanding, 
often requiring frequent blood glucose monitoring and insulin administration (at least 
4/day), control of carbohydrate intake, and altering insulin dose to match diet and activity 
patterns3. It is unsurprising that the use of complex routines can often result in poor 
glycaemic control which can cause serious and life threatening health complications for 
the patient4, and incurs great healthcare costs5. Management of T1D in children can be 
especially difficult given the unpredictability of their food intake and activity levels, as well 
as the need to negotiate management responsibilities at each developmental stage6.  
 
Insulin pumps 
The improved development and design of insulin pumps over time offers an alternative 
method of insulin therapy to the more commonly used multiple daily injections (MDIs). 
Insulin pumps are small devices weighing around 400 grams worn outside the body, 
which contain insulin- filled cartridges which continuously deliver insulin through a thin 
tube or cannula inserted subcutaneously around the abdominal wall4,6. Systematic 
reviews have suggested that insulin pumps may improve glycaemic control for children 
and young people4,7,8. Poor glycaemic control has been associated with increased 
prevalence of mental health difficulties, and subtle neuropsychological deficits9. Better 
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glycaemic control may therefore lead to improved cognition, behaviour and emotions for 
this group9. Furthermore, insulin pumps may offer improvements to a young person’s QoL 
compared to MDIs through facilitating a greater sense of control over diabetes, more 
independence, fewer physical complaints10, and more flexibility with diet and 
schedules10,11.  
 
On the other hand, some studies have found no significant difference in cognitive 
functioning and behaviour between insulin pumps and MDIs12. Moreover, a number of 
factors associated with insulin pump use which may negatively impact QoL have been 
reported. These include: the need for appropriate supervision of pump therapy in young 
children13; school related issues14; visibility of the pump14; infections at the cannula site 
and pump malfunctions14,15. In 2007, a systematic review was carried out to synthesise 
the literature on the impact of insulin pumps, and to ascertain whether pumps yielded QoL 
benefits for people with T1D. Their findings were inconclusive due to a number of poor 
quality studies in this field, and inconsistency in the assessment of QoL16. Although the 
evidence base for insulin pumps is ambivalent, pump use in the pediatric population is 
rapidly increasing6, with some governments investing heavily to increase the availability of 
insulin pumps for children and young people17,18. 
 
The impact of T1D on parents 
Intensive insulin regimens place great demands on caregivers of children with T1D. 
Numerous factors associated with carer burden, stress and anxiety have been reported 
including: the need to be constantly accessible to other caregivers, strain in the 
relationship between the family and the child’s school10; fear of hypoglycaemia19; 
engaging in anxiety provoking nocturnal blood glucose monitoring20; variability of food 
intake and monitoring activity levels21. These factors are associated with parental QoL19, 
diabetes self-efficacy22,23 and parental health24.  
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When considering the impact of the insulin pump on parenting a child with T1D, 
quantitative studies have suggested that insulin pumps reduce: overall parenting stress, 
worries about hypoglycaemia, problems with nutrition management21; anxiety25,26; and the 
frequency of parental contact with health services27. Similarly, a systematic review 
comparing insulin pump use to MDIs indicated that parents are more satisfied with the 
insulin pump7. Results from a randomized controlled trial (RCT) found that they may also 
experience improved QoL and less stress using the pump to manage their child’s T1D28. 
In contrast, a meta-analysis exploring the psychosocial impact of insulin pump therapy 
amongst adults, adolescents and children reported no consistent differences in anxiety, 
depression, QoL, self-esteem, and family functioning between MDIs and insulin pump 
therapy29.  
 
Marshall and colleagues30  have argued that the majority of studies attempting to explore 
parents' perceptions of caring for a child with T1D have used questionnaires with few 
studies adopting rigorous qualitative methods. Marshall and colleagues stated that a study 
could be considered rigorous if it provided “attention to detail at all stages of the study 
(from design through to presentation of findings)”30 (p. 1705). It has been suggested, 
particularly in diabetes research, that qualitative methods are especially useful in helping 
clinicians to answer questions that quantitative methods may not be able to. Specifically, 
qualitative methods have been described as being ideal for exploring patients' 
motivations, perceptions, expectations and experiences31. Understanding patients' 
experiences and beliefs are crucial to clinical care as they have a profound impact on 
health seeking behaviour and adherence to treatment31.  
 
Qualitative research has helped to improve our understanding of the experience of 
diabetes and its management from both the perspective of children and parents31. 
Previous qualitative studies have shown that young people often report their parents as 
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being anxious32, and overbearingly concerned about their diabetes management32-34. 
Alsaleh and colleagues35 carried out a systematic review to evaluate the contribution of 
qualitative studies to understanding parents and /or children and young peoples’ 
experiences of using the insulin pump for managing T1D. They searched a number of 
databases for qualitative studies published between 1970 and 2009 and found six studies 
which described the experiences of using the insulin pump from the perspective of 
children and/or their parents. Of these studies, five were reported as exploring parents' 
views of the insulin pump. Upon closer inspection, two of these five studies may have 
been constrained by the methods they used. Specifically, one study used postal self-
complete questionnaires36, and one administered the Schedule for the Evaluation of 
Individual Quality of Life (SEIQoL) over a telephone interview37. Additionally, a third study 
in this review failed to provide illustrative quotes and detail on method of qualitative 
analysis used. This made it difficult to understand the results and judge the quality of this 
study38. Qualitative studies that provide mainly descriptive data and fail to report 
qualitative method used and /or analysis offer few insights to the synthesis of qualitative 
literature39. Studies from this systematic review35 were described in detail, however 
findings from the studies were not synthesised. 
 
In light of the increasing rates of T1D in children and adolescents, and the increasing use 
of insulin pumps, it is important to systematically review the literature to explore parents’ 
views of the insulin pump. Although Alsaleh and colleagues35 provided a thorough review 
of experiences of the insulin pump from both parents and young people until 2009, only 
two of the studies within this review looked at parents’ experiences of caring for their child 
with T1D using the insulin pump using qualitative methods. The inclusion of studies using 
structured questionnaires and clinical interviews may have occurred due to the limited 
number of qualitative studies in this area at the time of review. To date, there have been 
no systematic reviews focusing purely on qualitative studies of parents’ experiences of the 
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insulin pump. A greater understanding of parents’ views of the insulin pump is needed to 
support parents in managing their child’s T1D, and to allow healthcare providers to offer 
appropriate supports. 
 
Aims 
To synthesise and discuss emerging themes from qualitative literature, exploring parents’ 
experiences managing their child/young person’s T1D using the insulin pump.  
 
Research Questions: 
1) What is known about parents’ views of the insulin pump from qualitative studies? 
2) How many studies have been published in this field?  
3) What is the quality of these published studies? 
 
Methods 
Search Strategy 
A systematic search of published studies related to parents’ experiences of using the 
insulin pump to manage their child’s T1D was performed using the following databases: 
Embase (OVID), Medline (OVID), Cochrane Library, PsycINFO (EBSCO), and Cinhal 
(EBSCO). Databases were searched for published journals from 1974 to 13th October 
2014. Key words used included “insulin pumps”, “CSII”, “experiences”, “narratives”, 
“patient satisfaction”, “patient attitude”, “parent”, “mothers”, “fathers”, “child”, “adolescent”.  
The results of searches using these key words were combined using “AND” and “OR” 
Boolean operators. As index terms vary across databases, individual search strategies 
were developed for each database based on the initial Embase search strategy (Appendix 
2). The same key search words and terms were entered in Google Scholar to search for 
additional papers and relevant grey literature.  
 
Reference lists of the included journals were also reviewed to obtain additional relevant 
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papers. In addition, articles from the European Diabetes Nursing and Pediatric Diabetes 
journals published in the last five years were hand searched to identify further papers. 
These journals yielded the highest number of relevant articles from the search strategy.  
 
New evidence published after 13th October 2014 will be described in an “updated 
research” section in the discussion of this paper; this will allow consideration of changes 
that may have occurred during this research period. 
 
Inclusion and Exclusion Criteria 
Inclusion Criteria: 
 Peer reviewed studies using qualitative methods and analysis to explore parents’ 
experiences of using insulin pump therapy to manage their child/young person's T1D  
 Studies published in English language 
 
Exclusion Criteria: 
 Studies describing experiences using implantable insulin pumps/closed loop systems/ 
sensor augmented pumps 
 Studies exploring experiences of adult pump users 
 Studies about Type 2 Diabetes (T2D) 
 Studies using quantitative methods 
 Case studies 
 Studies not published in English 
 Unpublished research 
 Studies that have not undergone the peer review process 
 Studies failing to describe a recognised approach to qualitative analysis or those that 
fail to provide illustrative quotations. 
 
Search Results 
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The search strategy produced 905 citations. Citations were screened for duplicates; 167 
were removed. The titles of the remaining 738 citations were screened and 640 were 
excluded. It was clear from the titles that these articles were either: not related to the 
target population (e.g. pregnant mothers, nurses, adults); not related to the insulin pump 
(e.g. closed loop systems, glucose monitoring systems); or were not qualitative studies 
(e.g. reviews, feasibility studies, questionnaire development studies). Abstracts of the 
remaining 98 articles were read, and 87 were excluded. Excluded articles were either: 
quantitative studies; review studies; case studies; or not related to the target population. 
Full texts were obtained for the remaining 11 articles. Of these, 4 were excluded for 
employing quantitative methods, or for not being related the topic of interest. References 
of the final 7 articles were screened but no new articles emerged. No new articles were 
obtained from hand searching the last five years of both Pediatric Diabetes and European 
Diabetes Nursing journals. A flow chart of this process is provided in Figure 1. Table 1 
provides detail on the seven articles included in this systematic review. 
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Figure 1: Flow chart of systematic search process and study selection 
Records identified through database searching (n=835): 
Embase 1974 (Ovid) -pres  n=391 
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Titles or abstracts screened (n=738) 
Excluded by title or abstracts (n= 
727); Reasons: 
Not relevant to the research topic 
n=598 
Not related to target population 
n=19 
Not qualitative methodology n=110 
 
 
Full-text articles assessed for 
eligibility (n=11) 
 
Full-text articles excluded (n=4); 
Reasons: 
Not relevant to the research topic 
n=2 
Not related to target population 
n=1 
Not qualitative methodology n=1 
 
  
Articles included in qualitative 
synthesis (n =7) 
 
Duplicates removed (n=167) 
 
Additional records identified 
through other sources (n=70): 
 
Google Scholar         n=70 
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Data Synthesis 
Meta-ethnography was chosen to synthesise the studies from this review and to generate 
new insights from the results. This method was chosen because it is, arguably, the most 
well-developed method for synthesising qualitative data40, and it has been successfully 
used for synthesising diabetes research41,42. Meta-ethnography involves selecting studies 
aimed at answering a specific research question to be synthesised, reading them 
repeatedly, and recording key concepts from these original studies. These key concepts, 
interpretations, and explanations from the original studies then become the raw data for 
the synthesis41. Noblit and Hare (p. 26-29)43 described a seven step process for carrying 
out a meta-ethnography to allow for new interpretations through synthesising findings from 
individual interpretative accounts. The seven steps are as follows:  
1) Getting started - deciding on a research question that is worth answering and one 
that could be informed by qualitative research 
2) Deciding what is relevant to the initial interest- deciding what would be of interest 
to your audience, including defining the focus of the synthesis, finding relevant 
studies, and making decisions about what should be included 
3) Reading the studies- becoming familiar with the content and detail of the included 
studies and noting emerging themes or metaphors 
4) Determining how the studies are related- creating a list of themes or metaphors, 
juxtaposing them, and determining how they are related 
5) Translating the studies into one another- comparing metaphors and concepts from 
each study with other included studies 
6) Synthesising translations- higher order interpretation of comparisons from step five 
leading to a line of argument synthesis 
7) Expressing the synthesis- presenting the results which is usually done through 
writing a paper for publication.  
 
In keeping with the meta-ethnographic approach, summaries of original findings, using the 
 12 
authors’ terms and concepts, were compiled for each of the studies. Lists of these 
summaries were noted side by side, on a single sheet of paper to facilitate comparison of 
relationships between concepts in studies. After identifying key concepts from each study, 
a systematic search was completed to identify whether or not these concepts were 
present in the papers to be synthesised. This synthesis began with the earliest study, 
Sullivan-Bolyai44, and continued by considering the presence or absence of each concept 
from this study within each of the other studies. Britten and colleagues explain that in a 
synthesis studies can relate to each other in one of three ways40. First, they may be 
directly comparable as reciprocal translations. Second, they may stand in opposition to 
one another as refutational translations. Finally, they may be taken together to represent a 
line of argument.  
 
Quality Assessment 
Authors in the field of qualitative research are divided on the issue of quality assessment; 
specifically whether poorer quality studies should be included or not, and which appraisal 
criteria to use39. A number of assessment tools for systematic qualitative reviews exist45-
49
. The 10 quality criteria outlined by the Critical Appraisal Skills Programme (CASP)48 
was used to assess study quality in this review. This tool was chosen as it has been used 
previously for assessment in meta-ethnographies41,50, and specifically in the field of 
diabetes41. The CASP assessment tool requires the author to answer ‘yes’, ‘partially’or 
‘can't tell/no’ to 10 questions to assess the rigour, credibility and relevance of each 
qualitative study. As is common practice when using quality criteria45, the tool was 
modified to allow a scoring system to be superimposed, this did not affect the validity of 
the CASP tool in itself as questions within the tool were not modified (see Appendix 3).  
 
Although authors in this field41 have used quality assessment to screen studies for 
inclusion in their meta-ethnography, it was decided a priori that every study meeting the 
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inclusion criteria of this systematic review should be included in the final analysis. This 
decision is in keeping with the third research question, specifically to understand the 
quality of studies published in this field. 
 
Scoring 
Studies were given 2 points if they provided enough detail to answer the quality question 
detailed in the CASP tool, 1 point if they partially answered the question and no points if 
they did not, or if it was not clear whether they had answered the question. Studies 
scoring >15 were classified as ‘good’, 10-15 as ‘acceptable’, and <10 as ‘poor’. Studies 
were assessed by the author and a second independent researcher. 
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Table 1: An overview of articles included in the review in year order  
Author(s) 
and Year 
Country Aims Methods  Duration of 
pump use 
Themes Quality 
Score  
/20 
Areas of Potential 
Bias 
Sullivan- 
Bolyai et 
al, 200444 
Massachu
-setts, 
USA 
To describe the 
experiences of 
parents managing 
the type 1 
diabetes of their 
young children 
using insulin 
pump. 
Interviews with 21 mothers 
and fathers of 16 children 
(2-11 years old with a mean 
age of 7) 
 
Content analysis was used 
to analyse the data. 
3-36 months • Introduction to the 
pump 
• Decision making 
process 
• Transition from MDI 
to pump 
• Day to day 
management with the 
pump 
• QoL with the pump 
17 Participants may have 
felt under pressure to 
take part as they were 
contacted by the PI 
directly 
 
More detail needed on 
bias from the 
researchers role  
Low et al, 
200514 
Maine, 
USA 
To use qualitative 
and quantitative 
methods to 
explore 
psychosocial 
issues related to 
insulin pump use 
in youth. 
Interviews with 18 
adolescents (11-18 yrs) and 
their parents about their 
experience of using insulin 
pumps.  
 
Content analysis was used 
to analyse the data. 
Mean =1.4. 
yrs 
• Pump therapy- 
expectations and 
benefits 
• Adjustments related 
to pump therapy 
• Social issues; 
liabilities associated 
with the pump 
• Wearing an insulin 
pump 
• School-related issues 
14 Not enough detail on 
recruitment strategy 
 
Data saturation not 
discussed 
 
No respondent 
validation 
 
No reflective diary use 
reported to allow the 
researcher to assess 
bias from their role 
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Table 1: An overview of articles included in the review in year order (continued) 
Author(s) 
and Year 
Country Aims Methods  Duration 
of pump 
use 
Themes Quality 
Score  
/20 
Areas of Potential 
Bias 
Pay, 
201151 
with 
additional  
informatio
n from 
Pay, 2009 
(Doctoral 
thesis 
provided 
in 
italics)52 
Queensla
-nd, 
Australia 
To gain an 
understanding of 
children and 
adolescents’ and 
their parents’ 
experiences of 
making the 
transition to insulin 
pump therapy. 
Questionnaires, diaries 
and interviews (before 
and 3 months after 
transitioning to the insulin 
pump) with12 
children/adolescents (3-
16yrs) and 11 parents.  
 
Content analysis was 
used to analyse the data. 
0-3 months The meaning of diabetes 
• Planning 
• Constancy of Diabetes care 
• Worries/concerns 
• Hypoglycaemia 
• Long term health 
Transition to insulin pump therapy 
• Starting over 
• Effort 
The meaning of insulin pump 
therapy 
• Fewer needles 
• Freedom and flexibility 
• Better control of blood 
glucose levels 
• Being attached 
• Feeling normal 
• Infusion Cannulas 
• Education 
 
      18 No reflective diary use 
reported to allow the 
researcher to assess 
bias from their role 
 
Data was not coded by 
a second researcher 
Olinder et 
al, 201153 
Sweden To gain insight into 
and generate 
theoretical 
knowledge about 
the processes 
involved when 
insulin pump 
treated adolescents 
take or miss taking 
their bolus doses. 
Interviews with 12 
adolescents (12-19 yrs); 4 
parents and 1 diabetes 
nurse. 2 adolescents and 
2 parents were re-
interviewed after 
10months.  
 
Grounded theory used to 
analyse the data. 
At least 3 
yrs. 
• Distribution of 
responsibility 
• Transfer of responsibility 
• Clarification of 
responsibility 
14 No reflective diary use 
reported to allow the 
researcher to assess 
bias from their role 
 
No respondent 
validation 
 
More justification on 
sampling needed 
 16 
 
Table 1: An overview of articles included in the review in year order (continued) 
 
Author(s) 
and Year 
Country Aims Methods  Duration of 
pump use 
Themes Quality 
Score  
/20 
Areas of Potential 
Bias 
Alsaleh et 
al, 201354 
London, 
UK 
To determine the 
views and 
experiences of 
parents and 
children regarding 
the training and 
services they 
received at a 
London teaching 
hospital when the 
child commenced 
insulin pump 
therapy; and to 
inform future 
services. 
Face to face interviews with 
38 parents and 34 children 
(5-17 yrs).  
 
A mix of framework 
analysis and grounded 
approach was used to 
analyse the data 
5m-7yrs • Initial worries and 
concerns regarding 
using the insulin 
pump 
• Participants' views 
about the structured 
multidisciplinary 
insulin pump 
programme 
• Recommendations for 
future services 
13 No reflective diary use 
reported to allow the 
researcher to assess 
bias from their role 
 
No respondent 
validation 
 
Not enough detail on 
method (sampling and 
analysis) 
 
No detail on how this 
study relates to Alsaleh 
et al 201455 and why 
they were written as two 
separate papers- author 
contacted but no 
response was given to 
this query. 
Alsaleh et 
al, 201455 
As above 
as these 
articles 
are from a 
single 
study of 
enquiry 
To examine the 
experiences of 
children/young 
people and their 
parents when 
switching to 
insulin pumps 
As above  • Pump therapy and 
glycaemic control 
• Adapting to pump 
technology 
• Home and social lives 
 
As above 
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Table 1: An overview of articles included in the review in year order (continued) 
Author(s) 
and Year 
Country Aims Methods  Duration of 
pump use 
Themes Quality 
Score  
/20 
Areas of Potential 
Bias 
Forsner et 
al, 201456 
Sweden To determine 
parents’ 
experiences of 
caring for a child 
less than two 
years old who had 
diabetes mellitus 
and was being 
treated with the 
insulin pump. 
Three sets of parents were 
interviewed twice. The 
second interview occurred 
6 months after the first.  
 
Content analysis was used 
to analyse the data. 
6-7 months Overarching theme:  
• ಯThe diabetes 
disease was 
threatening our 
baby's life, but then 
the insulin pump 
came as a rescuing, 
though challenging,  
angelರ 
 
1st interview: 
• Having your whole life 
turned upside down 
• Facing fears and 
obstacles 
• Being vulnerable yet 
confident 
• Regaining control 
 
2nd interview:  
• Being in control 
nearly all the time 
• Being challenged 
• Life goes on 
14 No reflective diary use 
reported to allow the 
researcher to assess 
bias from their role 
 
No discussion of 
discrepancies between 
authors 
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Results 
Quality Appraisal 
Five of the seven articles received the same score by the assessors (see Appendix 4). 
Discrepancies occurred because of different interpretations of some appraisal questions 
and were resolved through discussion. All of the articles were of ‘acceptable’ standard or 
above. As all studies fell above ‘acceptable’ standards based on quality ratings, findings 
were not weighted based on quality score. Quality scores did not appear to have made 
any real difference on the findings in this meta-ethnography as themes were similar 
between studies irrespective of the quality of the paper.  
 
Synthesis 
Table 1 provides an overview of the studies, emerging themes from each study, the CASP 
quality score, and areas of potential bias worth considering. Synthesis of the studies 
identified that the themes translated onto one another. Key concepts emerging from the 
analysis included: 
➢ Adjusting to the pump 
➢ Concerns regarding child wearing the pump 
➢ Freedom and flexibility 
➢ Responsibility sharing 
➢ Support for the pump 
 
Adjusting to the pump 
Adjustment to the pump was frequently discussed. Some parents described feeling 
surprised at how difficult it was to adjust to the pump, the extra work that was involved 
initially52, and the potential for difficulties to arise14, 52.  
 
“He had lots of things happen on the pump, practically everything that can go 
wrong” 14 (p.24) 
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The process of transitioning and adjusting to the pump was described as anxiety 
provoking14,56, tiring14,52, frustrating14 and “scary”44,56. Some reminisced that this 
experience felt like “starting over”; similar to when their child was first diagnosed with 
diabetes44,52. Parents reported being preoccupied caring for their child with T1D on the 
pump, with siblings feeling pushed aside56. Particular areas of difficulty reported included: 
cannula changes44,52; carbohydrate counting52,56; night time testing14,52,56; programming 
the pump and problem solving when something goes wrong55. 
 
“I don't have a clue really what to bolus for something from the bakery like that's 
what the dietician said. I remember the dietician saying have a guess if it’s 
something like a sweet dessert, have a guess and you can correct more on the 
lower side than on the higher side. When I do that, when I correct the next time 
the correction doesn’t seem to count up for what it should have been and so then 
he’ll go high again after that.”52 (p.51) 
 
Sullivan-Bolyai and colleagues44 described that the transition from MDI to the pump 
involved re-education of the child, the parents themselves and other caregivers. They 
reported that parents had to “rethink” the way they managed their child’s diabetes 
including learning to sleep through the night again. Interestingly, in other studies parents 
reported that they were challenged adjusting to pump therapy because initially they 
needed to check blood sugars frequently including during the night and were “very, very 
tired”14 from sleep deprivation14,55. Parents described that the timing of moving from MDIs 
onto the pump may be crucial as one programme which may be suitable for a week at 
school would be different to Easter holidays when lots of chocolate is consumed55. The 
adjustment process varied in length for parents; however studies reported that parents felt 
confident with the pump from between 6 weeks51 and 6-9 months44,56. This did not differ 
between parents of very young children56 and parents of older children44. Parents 
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reported that the initial adjustment to pump therapy had a great impact on their working 
lives with one parent reporting giving up work for six months55. 
 
“Yes the beginning of insulin pump therapy was terrible, so we actually did not 
work for 6 months. We did not do anything, we stopped everything”.55 (p.5) 
 
Concerns regarding child wearing the pump 
A number of parents expressed concerns about having their child hooked up to a “mini life 
support system” when making the decision to begin pump therapy44. These parents 
worried that the pump would malfunction giving the child too much insulin, or that the 
cannula would fall out. Parents also worried that their children would be stigmatised or 
bullied because of the insulin pump, or that other children would curiously press buttons, 
putting their child in harm’s way. Similarly, a father worried that the pump would be “an 
albatross” constantly reminding his child had he had diabetes44. Similar pre pump initial 
worries were reported by parents by Alsaleh and colleagues54. Parents most frequently 
worried about having a cannula constantly inside their child’s body, and worried that the 
pump might interfere with their child’s daily activities due to its size and shape54. 
 
Parents of younger children expressed concerns about the size and weight of the pump, 
and described having to sew pouches onto their child’s clothing to keep the pump from 
falling off44. Similar concerns about the size of the pump were expressed by parents with 
children under two years of age; one parent commented that the pump looked like a 
“ghetto blaster” on her tiny baby. Parents in this study also commented that the pump was 
always there, getting in the way when trying to care for their baby, for example when 
changing diapers56. 
 
Alsaleh and colleagues55 reported that although parents often worried that wearing a 
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pump would make their child more self-conscious of having diabetes and may render 
them vulnerable to being bullied. Some parents in this study also reported that the pump 
had a tendency to fall off or get in the way during sports. It is important to note that, when 
Low and colleagues14 compared parents with their teenage children they found parents 
tended to overestimate how uncomfortable their children were when responding to 
questions about the pump. Other parents reported that the pump appeared to have no 
effect on their child at all, except at meal times or physical activity14. Some parents said it 
could be hard to secure the pump to clothing without waistbands14. 
 
Similarly, Pay reported a theme in the data of “being attached”; parents reported that 
having their child “attached” to the pump was a disadvantage52. These parents worried 
about how their child would manage to sleep with the pump. Although most children 
adjusted to wearing the pump, one parent reported that her child stopped using the pump 
because she felt abnormal being hooked up to a machine. 
 
“K has told us that she no longer wants the pump because she feels that she is 
hooked up to a machine and does not feel like a normal kid” 52 (p.47) 
 
Freedom and flexibility 
Although glycaemic control was often cited as the main reason for initiating pump therapy, 
flexibility in terms of diet and meals (timing and size) was the most frequently mentioned 
benefit14,44. Parents mentioned that a big advantage of the pump was allowing their child 
the freedom to eat when they wanted14,52,55, to have a lie in if they wanted52, and to 
“vacation without a schedule”14. In addition to QoL benefits offered by this flexibility, 
parents said that this led to better nutrition management of their children44. Parents 
described the pump offered them freedom from the “slavery” of diabetes management.  
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“My husband said [we had] to leave because our son had to eat and it was close 
to dinnertime, and I said, “You know, we don’t have to go.” And it was such a 
liberating moment.....”44(p. 321). 
 
Parents reported benefits for the family too. They reported family life was less time driven 
and more spontaneous44, and that it was easier to eat out as a family without having to be 
so regimented about food55. Although generally parents reported that the flexibility with 
pump use enhanced social opportunities for their children, some parents reported specific 
social difficulties for their children such as attending “pool parties” and being outside in 
freezing temperatures which can impact pump functioning14. 
 
In contrast to other parents interviewed about the pump, parents of children under 2 years 
of age reported feeling pressure to be on top of things with the pump. They reported living 
in a “world of routines” but commented that the routines were both a strain and a source of 
security, and felt that even with a lot of routines they preferred the pump as MDI could not 
deliver the small amounts of insulin their baby needed56. 
 
ಯGod! The pens they’re like trying to fix a watch with an axe.ರ56 (p.10) 
 
Responsibility sharing  
Generating theoretical knowledge around the theme of responsibility for management of 
the insulin pump was the focus of Olinder and colleagues’ paper53, and was mentioned 
under other themes in most of the studies in this review. Olinder and colleagues 
interviewed parents and adolescents to understand the distribution of responsibility for 
diabetes management on the pump. The three themes exploring responsibility in this 
study were: distribution of responsibility, transfer of responsibility, and clarification of 
responsibility. Some parents in this study reported a struggle between helping their 
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adolescent child to become independent whilst also taking responsibility for their diabetes 
management. Parents said they offered more practical support to their adolescent children 
around the filling of the pump; changing infusion sets and reminding their child to bolus, 
however, they described a decline in such support once adolescents assumed more 
responsibility. Parents reported that the level of support from active to passive could shift 
back if the adolescent forgot to bolus at any point. Some parents said they wanted their 
adolescent children to know they were there to help when he/she was at home so that 
their adolescent child could relax knowing they were supported. This paper discussed the 
transfer of responsibility between the parents and adolescent as a gradual process which 
started when their child was very young, with more support being offered by parents when 
the adolescent is unwell, stressed, or when they have poor control. Parents described 
feeling frightened of relinquishing control with their adolescent child for fear of acute and 
late complications from poor diabetes management. This fear can be difficult for parents 
as they can feel stuck between wanting their adolescents to take more responsibility, and 
be more autonomous and being scared to let go of control of their adolescent child’s 
diabetes management.  
 
“Well, I’m really scared. Which I don’t tell S. I’m afraid she will end up in a 
situation where nobody understands that she needs help...”53(p. 1552) 
 
Parents discussed the need to clarify responsibility for diabetes management to allow 
necessary prompting of their adolescent child in aspects of management, such as bolus 
administration, without their adolescent child feeling that they are being constantly 
pestered by their parents. Similar discussions of parents and adolescents sharing 
responsibility for diabetes management on the pump were reported by Low and 
colleagues14, with parents assisting in aspects such as reminding to bolus, set changes 
and troubleshooting mechanical problems. 
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In keeping with Olinder and colleague’s53  discussion of a gradual transfer of responsibility 
for diabetes management, parents in Sullivan-Bolyai et al.44 reported that the pump 
empowered their children (those above age six) to became more involved in managing 
aspects of their diabetes such as: helping to insert the catheter, counting carbohydrates, 
and learning the mechanics of the pump.  
 
In addition to considering responsibility sharing between the parent and child/young 
person, responsibility sharing with other adults was discussed in a number of studies. 
Parents reported having to re-educate others who care for their children in managing 
diabetes with the pump, and reported that sharing diabetes management between adults 
was easier on the pump compared with MDI, because of the historical log which allowed 
parents to see whether insulin had been bloused44. Similarly, fathers were more involved 
in diabetes management because the mechanical aspects of the pump were perceived as 
a "guy thing"44.  Parents also reported that it felt easier to get a babysitter to care for their 
children on the pump, as pump management was perceived as easier than MDI44,52,55. 
 
In contrast some parents reported experiencing difficulties sharing responsibility for their 
child's diabetes on the pump with others. Parents reported difficulties getting schools to 
assist in pump management14; and some felt that difficulties explaining complex pump 
management were a barrier to leaving their child with others55,56. Parents also reported 
that their children received fewer social invitations from others and wondered whether 
other parents felt frightened to take responsibility of the pump55. Similarly, parents of 
children less than two expressed anxieties about leaving their child with someone else on 
the pump and reported feeling isolated56. 
 
ಯOf course we felt very alone. Very alone.... There wasn’t anyone else.” 56 (p.9) 
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Support for the pump 
The need for continued support, extra education sessions, and discussions about pump 
malfunctions were commonly mentioned in interviews with parents. Although most 
reported pump training by diabetes clinics as really helpful54,56, parents often commented 
that additional education would allow them to discuss some of the more complex 
management concepts of the pump44, and offer them additional practical tips for 
managing the pump52. Parents reported finding 24 hour support 7 days a week 
particularly helpful when learning how to use the pump, with additional contact details and 
further support also necessary54. Opinions regarding support provided to schools were 
mixed; some parents reported that support helped schools to feel more equipped to 
manage emergencies with the pump, whilst others said that information provided to 
schools was excessive54. 
 
Parents spoke about feeling vulnerable and dependent on Diabetes nurses in the initial 
period after beginning pump therapy with their very young children. When these parents 
were followed up six months later, however, they reported increased confidence in 
managing pump therapy alone56. Other parents reported that support from diabetes clinics 
helped them the feel like they could cope44. 
 
Pump malfunctions were mentioned in some interviews14,44,55, with "liabilities associated 
with CSII" being a theme to emerge in one paper14. Some parents reported having 
problems with site infections44, the pump freezing55, difficulties with air bubbles55, static 
interference impacting pump functioning14, and problems with the cannula44,55. Although 
pumps are often equipped with alarms to indicate potential difficulties, some parents 
reported that these alarms made their children feel nervous14. Parents reported pump 
malfunctions as very anxiety provoking but accepted that it was part of pump therapy14. 
 
 26 
“When something malfunctions, it is a disaster... and we have had many a 
sleepless night because of that. But, you know it kind of comes with the 
territory”14(p.27) 
 
Parents mentioned that it was helpful to have support, and a quick response from pump 
manufacturers when a problem arose14,44. 
 
Discussion 
 
 
This systematic review synthesised qualitative studies exploring parents’ views of the 
insulin pump to gain a better understanding of these views and experiences. There were 
few studies in this field. Of the seven articles included in this review, two were specific in 
their focus; exploring parents views of insulin pump training in a hospital in London54 and 
looking at a theoretical understanding of responsibility sharing around missed boluses53. 
Despite these articles with specific foci it was possible to identify five key themes amongst 
the research: 1. adjusting to the pump, 2. concerns about a child wearing the pump, 3. 
freedom and flexibility, 4. responsibility sharing and 5.  support for the pump. 
 
Many parents described challenges involved in adjusting to the pump which were 
frequently referred to as anxiety provoking. As part of this adjustment, parents often 
engaged in anxiety driven nocturnal testing, had concerns about having their child hooked 
up to a pump, worried about how others would react to the pump, and had to overcome 
challenges of finding ways to keep the pump attached to their child. The paediatric 
transactional theory57 emphasises the importance of gaining an understanding of these 
stressors and experiences of a parent caring for a child with chronic illness as these 
factors are associated with the child’s health and behaviour. In addition, these factors 
have been associated with parental health24, QoL19, and diabetes self-efficacy22,23. 
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Although the two aforementioned themes (adjustment to the pump; concerns regarding 
child wearing the pump) are centered around some of the more challenging aspects of 
pump experience, parents often commented that these difficulties were worth it for the 
freedom and flexibility the pump offered their child. Interestingly, qualitative research 
exploring young people’s experiences of the pump has mirrored this finding; even though 
there can be negatives to pump use (for example, being bullied); there are also positives 
to pump use (for example, greater freedom to socialise), with young people generally 
preferring the pump in comparison to MDI11.  
 
Parents of older children commented that the pump made it easier for them to share the 
responsibility of diabetes management with their child’s other caregivers44,52,55, however, 
parents of children aged two and under felt that it was sometimes difficult to get support 
caring for their child and felt isolated56. Different challenges caring for a child with T1D 
depending on the child’s developmental stage are in keeping with guidance from the 
American Diabetes Association on standards of care for children and adolescents with 
T1D6. Although numerous quantitative studies exist on glycaemic benefits on the insulin 
pump, it is interesting to note that QoL benefits such as increased freedom and flexibility 
are more frequently mentioned in the studies than glycaemic control. These findings may 
lend support for studies indicating improved QoL for parents and children on the insulin 
pump compared with MDI29. This observation merits further exploration in future studies 
on parents’ experiences with the insulin pump. Similarly, positive support from parents 
allowing their child to take on more responsibility has been associated with increased 
adolescent adherence to treatment regimens58. Parents felt that the pump facilitated 
sharing of responsibility with children above six years of age44. 
 
Parents acknowledged that the pump is a machine and like other machines is complex 
and can malfunction, therefore it was felt that ongoing support is needed to help them to 
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cope when these difficulties arise. This finding is in keeping with Weissberg-Benchell and 
colleagues’ meta-analysis29. They reported that pump malfunctions and technological 
difficulties were commonly reported problematic situations for families with adolescents 
using the insulin pump. Studies have suggested that difficulties using the insulin pump are 
a common reason for children or adolescents discontinuing pump therapy59. Guidance on 
caring for a child with T1D generally (regardless of method of insulin delivery) has 
highlighted the importance of continued support and education6; this may be particularly 
useful for families encountering pump-related difficulties.  
 
Quality of studies in this meta-ethnography 
Most of the articles received high scores for quality questions related to the aims of 
research, the appropriateness of method for research aims, and for detailing the value of 
the research. Studies commonly failed, however, to adequately consider the relationship 
between the researcher and the participants, with consideration of researcher-participant 
reflexivity often absent from studies. Articles also received lower scores for not providing 
enough detail on data analysis, specifically why they chose a particular method, and steps 
taken to allow the reader to consider whether this was appropriate and sufficiently 
rigorous. Word limits imposed by journals might have impacted on the level of detail 
provided, thus lowering quality scores. This was evident when comparing Pay’s published 
study51 with her doctoral thesis52. The level of detail provided in the thesis increased the 
quality score from “acceptable” to “good”. 
 
When considering bias in the studies, a method of respondent validation was often absent 
which impacted on the reader’s ability to determine how accurately the themes reflected 
participants’ experiences. It was often unclear how authors decided when they had 
enough data to answer the research question as sample size considerations or saturation 
of data were not mentioned in some studies14,53-55. 
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Strengths and Limitations 
Of the seven articles included in this meta-ethnography, five articles14,44, 52, 55,56 translated 
into each other well with similar concepts emerging from parents’ experiences in each 
paper. The more focused studies by Alsaleh et al54 and Olinder et al53 did not synthesise 
as well with the other papers. For example, although responsibility sharing was the focus 
of Olinder and colleagues’ study and therefore synthesised well with other studies also 
addressing responsibility sharing, concepts common to these other studies14,44,52,55,56  
could not be mapped onto this study because the focus was restricted to responsibility 
sharing. In retrospect, perhaps if there had been a greater number of qualitative studies 
that explored parents’ views of the insulin pump more generally then these studies would 
have been excluded because their specific aims may impact on the understanding of 
wider issues for parents caring for a child on the insulin pump. Similarly, it is also worth 
noting that although the two papers by Alsaleh and colleagues54,55 focused on different 
aspects of parents’ experiences of the insulin pump they were from a single study of 
enquiry.  
 
A limitation of this review is that sampling bias may have impacted on the findings 
presented. It is likely that parents who took part in the studies were highly motivated to 
share their experiences, whereas those who decided not to participate may have had 
different perceptions and experiences of the pump. It is important to consider that the 
studies were carried out in a range of geographical areas from America, Australia, 
Sweden and the UK. Different healthcare systems and provisions may also have impacted 
on the findings presented. Similarly, it was not clear from these studies whether different 
cultures and ethnicities were represented in the research. Limiting the search to studies 
published in English language meant that studies in different cultural contexts may have 
been missed. The age ranges of children parented were often very wide in the studies 
included e.g. 2-11 years44, 3-16 years51, and 5-17 years54, it was therefore difficult to 
analyse differences in parents’ experiences based on the age of their child throughout this 
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meta-ethnography. Given these limitations it is likely that this review is limited in 
understanding parents’ views of the insulin pump; however the intention of this review was 
not to generate generalisable findings but to gain an in depth understanding of parents’ 
experiences of using the insulin pump. 
 
A recent systematic review highlighted that qualitative research is rarely published in high 
ranking journals60; this finding combined with the exclusion of unpublished research from 
this review may have limited our understanding of the topic area. Although the studies 
included in this review spanned a ten year period and covered experiences of parenting 
children across the developmental range from two to nineteen years of age, common 
experiences could be identified between studies. More qualitative studies in this field 
could allow for a stratified analysis to be carried out which may capture the different care 
needs for each developmental stage.  
 
Updated Research 
Since this review was carried out, Rankin and colleagues61 published a qualitative study 
exploring 19 parents’ experiences of managing their children aged 12 or younger, with 
T1D on the insulin pump. In keeping with this review, parents reported benefits from the 
pump in terms of more freedom and flexibility at mealtimes and with life generally. 
Similarly, responsibility sharing was also discussed by these parents within the theme 
“more work for parents and other caregivers”. Other themes from this study that did not 
emerge in the present review included: “benefits of bolus advisors”, “more work to address 
perceived risks of hypoglycaemia”, and “more work because parents can do more to 
manage their child’s diabetes”. Further qualitative studies in this field may allow for more 
convergence with themes from this study that did not emerge from the meta-ethnography. 
 
Reflexivity 
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This review was completed while the author carried out research into parents’ experiences 
of caring for a child with T1D using the insulin pump. These experiences may have 
influenced the author’s secondary interpretation of the papers. 
 
Clinical Implications 
This review suggests that parents of children with T1D using the insulin pump can 
experience difficulties with the change from MDI management. These initial difficulties can 
be around cannula changes or anxieties about their child constantly being attached to a 
pump. The majority of parents reported benefits of the insulin pump for family flexibility 
and for sharing the responsibility of diabetes care with others, however, a number of 
parents indicated that they would like more information and education on using the pump 
over and above the support already received. More knowledge on some of the more 
difficult aspects of the pump and how to manage these could help normalise parents’ 
experiences, decrease anxieties, and increase adherence to pump therapy. Some parents 
identified that the process of adjusting to the pump was very anxiety provoking; more 
guidance on supporting parents with anxiety related to diabetes management at this time 
could ensure that parents’ psychological needs are better supported, which may impact on 
the parent and child’s level of distress, and subsequent glycaemic control6.  
 
Research Implications 
The care needs and levels of support required by children differ according to the child’s 
developmental stage6. More research focusing on parents’ experiences of the pump for 
children at different developmental stages could provide greater understanding of the 
challenges and support needs at each stage. Similarly, only two studies included in this 
review looked solely at only parents’ views. Being involved in a study whereby the parent 
is aware that their views will be examined alongside their child’s may have impacted the 
data provided. Furthermore, as the findings from this review were based on studies 
conducted in four countries with different health care systems in operation, more research 
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across different countries, cultures and ethnicities is warranted to gain a better 
understanding of experiences for specific population groups. 
 
Conclusion 
Parents play a pivotal role in supporting their child with T1D using the insulin pump, 
however few qualitative studies exist to understand parents’ experiences of this insulin 
management process. This review emphasises that although parents face challenges and 
experience anxiety in certain areas of pump therapy, these challenges are commonly 
accepted for the increased freedom and flexibility offered by the pump. Further studies 
aimed at understanding parents’ experiences of caring for a child with T1D using the 
insulin pump at different developmental stages could help to tailor support offered to 
parents at each stage.  
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Plain English Summary 
Background 
Type 1 Diabetes (T1D) is an illness that usually starts during childhood and requires 
treatment with a combination of insulin injections, blood sugar tests, dietary control and 
exercise. Traditionally, insulin was delivered by multiple daily injections; however, the 
development of insulin pumps which deliver insulin through a small tube inserted under 
the skin has resulted in another method of diabetes management. Insulin pumps may offer 
benefits to people with T1D, e.g. improved blood sugar control, quality of life (QoL), 
thinking skills and behaviour. Although parents play a lead role in helping their children 
manage their diabetes using the insulin pump few studies have looked at the impact of the 
insulin pump on parental quality of life.  
Aims 
To explore the views of parents who manage their children’s T1D with insulin pumps with a 
particular focus on the impact of the insulin pumps on their quality of life. 
Methods 
Following ethical approval and informed consent, seven parents of children aged 12 or 
younger with T1D, and who had used the insulin pump for nine months or more, were 
invited to participate in this study. The researcher carried out interviews lasting about 50 
minutes each, these were digitally recorded, typed out word for word, anonymised and 
analysed to gain an in-depth understanding of what it is like to care for a child with T1D 
using the insulin pump. 
Main Findings and Conclusions 
Four themes described parents’ experiences caring for their child using an insulin pump: 
life before the pump, transition to the pump, life on the pump, and the perceived impact for 
their child. On the whole parents were happy with the pump, although parents explained 
that there were both positive and negative aspects to using the pump. This study may 
help to inform the care that parents of a child with T1D receive from their diabetes team.  
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Abstract 
Background: Insulin pumps have the potential to improve glycaemic control and health in 
childhood type 1 diabetes (T1D) but they require intensive monitoring and their impact on 
parental quality of life (QoL) is less well understood.  
Aims: To explore the views of parents who manage their children’s T1D with insulin 
pumps, with a particular focus on the impact of this method of insulin delivery on parental 
QoL. 
Method: A qualitative, cross-sectional study was conducted. Seven parents with a child 
aged 12 or younger with T1D, who have used the insulin pump, were recruited using 
purposive, volunteer sampling. Semi structured interviews were carried out and analysed 
using interpretative phenomenological analysis (IPA). 
Results: Four super-ordinate themes describe parents’ experiences adjusting to caring 
for their child using an insulin pump; ‘life before the pump’, ‘transition to the pump’, ‘life on 
the pump’, and the ‘perceived impact for their child’. Each super-ordinate theme 
comprised several sub-themes, and a concept that crossed all themes was ‘fluctuating 
feelings of control’. 
Conclusions: Parents were generally positive about using the insulin pump to care for 
their child with T1D, and most wished to continue with this method of insulin delivery. 
Parents faced challenges at particular times with the pump, but with support regained 
control over difficult aspects of pump use. Understanding parents’ experiences will assist 
diabetes teams to implement care practices centred on the needs of the family. 
 
Key words: Insulin Pumps; Type 1 Diabetes; Children; Young People; Parents 
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Introduction 
T1D is one of the most common chronic childhood illnesses with incidence rates rising 
rapidly in the last ten years in Europe, Australia and the United States of America (USA)1. 
Management of T1D requires continued attention to a number of factors which can each 
impact glycaemic control including: insulin administration, blood glucose monitoring, 
physical activity, and meal planning2. Complications in glycaemic control may affect the 
eyes, kidneys, nerves and cardiovascular system and in some cases may lead to coma 
and even death3.Recommended treatment of T1D includes intensive insulin replacement 
therapy to try to achieve near optimal glycaemic control; this is often a challenge for 
children, young people, and their families4.  
 
Insulin pumps 
Insulin pump therapy offers an alternative to the more traditionally used multiple daily 
injections (MDIs). Insulin pumps are small devices worn outside the body, which 
continuously deliver insulin through a thin tube or cannula inserted subcutaneously. The 
insulin can be delivered at a set rate or increased when needed, for example at meal 
times. It is advised that the cannula be replaced and repositioned every three days5.  
 
A Cochrane review of 23 randomised controlled trials (RCTs) (including seven with 
participants below 18 years of age) comparing insulin pumps with MDIs reported that 
insulin pumps may result in improved glycaemic control compared with MDIs3.Guidelines 
recommended the use of insulin pump therapy for children and young people who present 
with either: recurrent severe hypoglycaemia, suboptimal glycaemic control, microvascular 
complications and/or risk factors for macrovascularcomplications, or for those who have 
good glycaemic control but whose insulin regimens compromise their lifestyles6. 
 
Insulin pumps and QoL 
Studies about insulin pump therapy tend to focus on clinical effectiveness and medical 
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outcomes from this method of insulin delivery7,8. It may be the case that benefits occur 
over and above good glycaemic control. For example, improved glycaemic control is 
associated with benefits in cognition, behaviour and emotions9. A number of clinical 
specialists, patient experts and studies have indicated that the use of insulin pumps yield 
a number of QoL benefits, including: greater flexibility in routines and diet, less physical 
burden6,10; autonomy, spontaneity, socialisation, improved sleep10; and decreased fear of 
hypoglycaemia11.  In contrast, factors associated with pump use have also been reported 
which may negatively impact QoL such as: cannula site infections11; pump 
malfunctions11,12; supervision requirements of pump therapy in young children12,13; school 
related issues12; and the visibility of the pump10,12. A systematic review which explored the 
literature, and tried to ascertain whether pumps yielded QoL benefits for people with T1D 
stated that their findings were inconclusive due to poor quality studies in this field, and 
inconsistency in QoLassessment14. 
 
The impact of the insulin pump on parenting a child with T1D 
The task of managing T1D in young children rests almost completely on adult carers. A 
wide variety of carer burden, stress and anxiety has been reported including: food intake 
variability, activity level monitoring15; having to be constantly available to other caregivers, 
tension in the relationship between the family and the child’s school6; carrying out anxiety 
provoking nocturnal blood glucose monitoring16; and fear of hypoglycaemia17. These 
factors have been shown to affect both parental health18and QoL17. 
 
Some studies have suggested that insulin pumps allow parents of children with T1D 
greater ﬂexibility, spontaneity and freedom in their lives6; reduced parental stress and 
worry regarding their child’s overall care6 and glycaemic control15; and greater confidence 
and independence in managing their child's diabetes19. Similarly, a Scottish qualitative 
investigation of the effect of the insulin pump on young people’s QoL found that they 
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reported less parental burden and more parental support with the insulin pump compared 
to MDIs10. A meta-analysis investigating the psychosocial impact of insulin pump therapy 
found no consistent differences in QoL, self-esteem, anxiety, depression, and family 
functioning between insulin pump therapy and MDIs20.  
 
Gaps in the knowledge base 
In conclusion, studies about the impact of insulin pump therapy on QoL in T1D yield 
conﬂicting results. A recent systematic review emphasised that there is limited qualitative 
data examining experiences of parents caring for children with T1D using insulin pumps21. 
This review and individual studies focusing on parents’ experiences of caring for children 
with T1D have underlined the scarcity of research in this area; authors in this field have 
concluded that further investigations of parent QoL are warranted16,22. These gaps in the 
evidence base are particularly relevant within the Scottish context, given the increased 
provision of insulin pumps amongst the Scottish paediatric population23, driven by 
Government investment24.  
 
Aims 
This study aimed to explore parents’ views of managing their children’s diabetes with 
insulin pumps compared to MDIs.  
 
Objectives 
(I) To explore the views of parents managing their children’s T1D with insulin pumps 
(II) To investigate the perceived impact of the insulin pump on parents’ QoL* 
 
*There is a lack of agreement on the definition of QoL, or how best to measure this within 
health and social research. In keeping with the work of Joyce and colleagues25, and for 
the purpose of this study, QoL will be what the participant chooses it to be; they “alone can 
define it and assess its changing personal significance” (p.121). 
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Methods 
Design 
The present study was an exploratory qualitative study and used Interpretative 
Phenomenological Analysis (IPA). IPA aims to explore flexibly and in detail how the 
research participant makes sense of their experiences, while acknowledging that the 
analysis of this exploration of experience is influenced by the researcher's interpretation of 
these views26. The IPA approach has been commonly used to explore experiences with 
illness27. 
 
Participants 
In keeping with IPA principles, a purposive, well defined homogeneous sample26of parents 
of children with T1D, attending a Scottish paediatric diabetes clinic was recruited for this 
study. The intention of this study was not to provide a generalisable account of parent’s 
experiences managing T1D using insulin pumps, but to provide an in-depth account of 
each individual's experience of their child’s diabetes management, whilst also allowing 
exploration of similarity and difference of experiences within the sample. 
 
Consistent with developmental stages28, research into children with T1D is often divided 
into age bands of 12 years or younger, and above 12 years of age29. This study focused 
on the experiences of parents with children aged 12 or younger with T1D who use, or 
have used the insulin pump, because parents will play a crucial role in helping their 
children to manage their diabetes during these younger years. It can take parents six 
weeks to nine months to feel confident using the insulin pump after initializing pump 
therapy30; to prevent initial confidence issues from influencing the data, parents with less 
than nine months experience using the pump were excluded. Due to the exploratory 
nature of this study, both genders of parents were included; this is consistent with other 
research in this field30,31.  
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Inclusion criteria 
 Has a child aged 12 or younger with a diagnosis of T1D and has used (current or  
past use) an insulin pump for at least nine months  
 Child (and siblings) has/have no additional major chronic health conditions 
requiring hospital attendance 
 Fluent in English 
 Has a child attending the recruiting hospital 
 
Recruitment Procedure 
Recruitment packs were sent to a random sample of 25 parents identified as meeting 
inclusion criteria. Posters were also put up in the waiting room of the Diabetes outpatient 
department to invite eligible parents to take part. Interested participants were contacted, 
and an appointment was arranged to conduct the interview within the diabetes clinic. 
Written informed consent was obtained prior to conducting the interview. See appendices 
6-10 for forms used during recruitment. 
 
Of the 25 parents invited to take part in this study, nine made contact with the researcher 
and seven agreed to be interviewed. Six were mothers, one was a father, their children 
were between seven and twelve years old at recruitment; all were from two parent families 
(see Table 2). By the seventh interview, it was observed that similar themes and 
experiences were being spoken about in the interviews, with no new themes arising; data 
had therefore reached saturation within this sample.A number of sample sizes for IPA 
have been suggested26,32. This sample size is consistent with the recommendation of 
between four and ten participants for a professional doctorate (p.52)32. 
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Table 2: Summary of participant demographics 
Parent Mother/Father Age and Sex of 
child at recruitment 
Age at T1D 
diagnosis (yrs) 
Duration on the 
pump (yrs) 
1 Mother 10 F 5 4.0 
2 Mother 12 M 6 1.6 
3 Mother 9 M           4 2 
4 Mother 7M 1 3.4 
5 Mother 10 F           7 1.1 
6 Mother 9 F           4 2.5 
7 Father 12M           4 1.2 
 
Research Procedures 
An interview schedule was developed based on the existing literature and through 
discussion with the principal researcher and supervisors (Appendix 11).The interview was 
semi structured using the interview schedule as a starting point but allowing for areas that 
arose spontaneously to be explored. It was piloted on the first three interviews, judged to 
be effective and, therefore, was not modified for subsequent interviews. Interviews were 
carried out in September and October 2014. Interviews lasted between 35-70 minutes, 
and were recorded using a digital voice recorder, transcribed verbatim and anonymised.  
In keeping with other qualitative research33, at the end of each interview the participant 
was asked to summarise the main points discussed, and to rank summary points in order 
of importance, as a form of respondent validation.  
 
Analysis 
Interviews were analysed consistent with IPA guidance (p. 79-107)34. Each transcript was 
read a number of times and annotated in detail to identify interesting or significant points 
raised. Comments were recorded which connected or summarised significant discourse 
within each transcript, and to identify at a higher level of abstraction the essence of the 
text. Preliminary themes reflecting the participant’s experience were then identified for 
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each transcript, followed by the identification of emerging themes. Emerging themes for all 
participants were then charted. During charting, a number of themes appeared to cluster 
together, this allowed grouping of these themes as super-ordinate themes. Within each 
theme it was possible to identify similarities of experience, and areas of difference.  
Restructuring and regrouping of themes occurred throughout the analysis process.  
Extensive note taking and use of a reflective journal by the principal researcher throughout 
data analysis allowed the interpretative thought process to be recorded for transparency, 
and helped to facilitate the identification and minimisation of researcher bias. 
 
An adaptation of Kreuger and Casey's35long table approach was used to sort data. This 
involved cutting, sorting and arranging data into categories, on a long table. Each quote in 
the transcript was given a unique identifier; data were copied and pasted into groups and 
subgroups based on the emerging themes. This approach is recommended for a novice 
qualitative researcher rather than using qualitative analysis software since the long-table 
approach involves visually sorting information which facilitates data familiarity35. Validity 
criteria for promoting rigour in qualitative research were followed36. A transcript was 
independently analysed by a second experienced researcher supervising this project to 
assess inter-rater reliability. Agreement was achieved in terms of the content of salient 
themes, although wording used to describe the themes differed slightly.  
 
This study was approved by NHS Greater Glasgow and Clyde Research and 
Development Team and The North of Scotland Proportionate Review Research Ethics 
Committee approved the study (appendices 12-13). 
 
Reflexivity 
The IPA approach acknowledges explicitly that the researcher’s beliefs and experiences 
will influence their understanding of the participant’s experience32. The principal 
researcher, a trainee clinical psychologist, did not have prior clinical experience, personal 
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experience, or in-depth knowledge of diabetes before commencing this project. This study 
was however carried out whilst the author was also completing a meta-ethnography 
exploring parents experiences of the insulin pump. To prevent bias from results of this 
meta ethnography from influencing this study, the author referred back to parents 
summaries of important points from the interview during the analysis process (appendix 
14), and a transcript was independently coded by a second experienced researcher. 
 
Results 
The focus of this study was to explore parents’ experiences of managing their children’s 
T1D with insulin pumps. During the interviews parents also spoke about their experiences 
of having a child with T1D more generally. To remain focused on the study aims only the 
shaded themes specifically related to parents’ experiences with the insulin pump will be 
discussed. Super-ordinate themes are presented in keeping with the temporal sequence 
of parents’ lived experience, starting with life before the pump, transitioning to the pump, 
and life on the pump including considering the impact for their child. 
 
Table 3: Super-ordinate and emergent themes 
Super-ordinate themes Emergent themes 
Initial diagnosis  Noticing symptoms 
 Seeking help 
 Emotional adjustment to diagnosis 
Life before the pump  Control/ helplessness 
 Anxiety associated with rigidity of meals 
Transition to the pump  Getting a pump 
 Upheaval 
 Finding own way with the pump 
 Support 
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Life on the pump  More effort 
 Parents’ emotional well-being 
 Perceptions of glycaemic control 
Perceived impact for their 
child 
 Developing autonomy- benefits and challenges 
 Child’s emotional well-being 
 
Life before the pump 
The super-ordinate theme ‘life before the pump’ involved parents looking back and 
considering what life was like on MDI to provide a context for their experiences using the 
pump. Key emergent themes when reflecting on this time were issues of control and 
feelings of helplessness, and anxiety. 
 
Control / helplessness 
Parents spoke about their perceptions of control using MDI. Although most parents 
reported feeling helpless on MDI, describing that no matter how hard they tried, they 
struggled to get good glycaemic control for their child, two parents felt MDI allowed them 
good glycaemic control, with one parent highlighting that she felt more secure using MDI 
with her son. This mother had experienced multiple pump malfunctions, and struggled to 
get the right support to help her feel like she understood the pump:  
 
“I can work out the needles, I can work out when he’s on the pens, I know exactly 
what I’m doing, I just find this (the pump) very stressful.” (Parent 2, line 152) 
 
Half of the parents described constantly having to “feed insulin” carrying out up to six 
injections a day to get their child’s blood sugar under control, and frequently being sleep 
deprived as a result of correcting their child’s blood glucose levels throughout the night: 
 
“The night times particularly were very hard you know…… we caught many of his 
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really severe lows when he was sleeping which he never woke up from, and 
regularly we were catching highs which we were correcting for throughout the 
night, em you know so it was very, we got what was classed as a reasonably 
good HbA1cbut to get that we were sacrificing a huge amount” (Parent 4, line 78) 
 
One mother spoke about having her sense of hopelessness on MDI confirmed and 
reflected by her GP: 
 
“ Her HbA levels started going up, the doctor basically said to us “there’s no more 
answers”, you know we had tried them all, nothing worked, nothing brought her 
levels down” (Parent 1, line 125) 
 
Feelings of helplessness seem to be particularly acute when parents were unable to 
intervene with rising blood glucose levels: 
 
“I felt so helpless when he was sitting there after injections and his blood sugar 
was 12, 14, 16 and all you can do was sit, there’s nothing you could do, and I just 
felt so helpless watching him stew in syrup” (Parent 7, line 310)” 
 
Anxiety associated with rigidity of meals 
Most parents described feeling anxious and panicked at having to stick to rigid ways of 
eating whilst using MDI. This impacted on the whole family’s routines.  
 
“We did get a bit panicky, even within the very set routine we had, we started to 
get a bit panicky or nervous about getting (dinner) at exactly six o’clock, exactly 
at this time, everything perfect… we had to also modify our diet, there was less 
sugar, less treats, less cakes..”  (Parent 7, line 148) 
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“It was hard you know having to do injections if we were out somewhere, having 
to find somewhere private to do injections….having to find a toilet and having to 
go in and inject, and I don’t like doing that in toilets”. (Parent 6, line 442) 
 
One mother described having to engage in parenting behaviours that seemed 
paradoxical, such as force feeding her daughter chips in a restaurant if her daughter had 
ordered them and then no longer wanted them. Similarly, she described a range of anxiety 
provoking imagined scenarios, which were outwith her control, where she worried her 
daughter would not be able to eat what she had injected for:  
 
“I was writing on her lunch box “this is your carb count for the day”, so she would 
dutifully put that number of units, inject it, and then she could throw her 
sandwiches in the bin, and it did, it really did worry me sick”. (Parent 5, line 451) 
 
Another mother described how upsetting it was not being able to give her son the same 
treats as his brothers, feeling stressed when she could hear the ice cream van outside, 
and having to come up with elaborate reasons why her son’s smaller treat was better. This 
mother described how other adults’ lack of understanding of diabetes and food caused 
additional stress and tension for her family: 
 
“Other people’s understanding was awful at times, coming up and waving 
something in front of his face and saying “can he have this?”.... we left family 
parties and we left things half way through, we thought “this is too hard, let’s just 
go home”. You know it wasn’t fair on him, it wasn’t fair on the other kids, it 
created tensions between the adults”. (Parent 4, line 59) 
 
 
Transition to the pump 
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The super-ordinate theme ‘transition to the pump’ contained emergent themes which 
described parents’ struggles to get their child on a pump, a sense of upheaval when first 
using the pump, how they adjusted at this time, and the support that was needed to allow 
this adjustment in many cases.  
 
Getting the pump 
Parents commonly heard about the pump through diabetes support groups or through 
friends of their families. Most parents felt that they needed the pump because they were 
not getting good glycaemic control on MDI. Five parents spoke about approaching their 
health care team for the pump but were told that either there was no funding for the pump, 
or that they were not eligible for it. Three of these parents described the sense of 
frustration and anger which had led them to fight for a pump through contacting local 
papers, threatening to contact their minister of parliament (MP), or through moving 
hospital with their child.  
 
“We had to go to six injections a day because they weren’t working, and that’s 
when we had to fight to get the pump… we had to go to the local papers to get 
the pump… we were told that it was the only thing that would help because there 
was no money for funding” (Parent 1, line 112) 
 
“He (endocrinologist) kind of mentioned the pump although was aware that our 
hospital didn’t support it at that point… We kind of felt we weren’t getting 
anywhere, we couldn’t move forward so we asked for a referral, we had to kind of 
fight to get the transfer of hospital” (Parent 4, line 114) 
 
One mother pointed out the injustice of feeling that she was being punished for all the 
effort she was putting into getting her daughters diabetes under control: 
“I said “so because were managing (daughter’s) diabetes well we’re being 
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punished for it”, and I said “look this has to stop, this cannot be”, and I said which 
I probably shouldn’t have said “well I can get (daughters) count up and down like 
a yoyo” but what parent would do that because that’s her health..... so I did say 
“well I’ll be going to my MP because this is not good enough.” (Parent 5, line 84) 
 
Upheaval 
Struggling to adjust especially in the first days after going live on the pump was a common 
narrative amongst parents. Areas of difficulty included learning how to programme the 
pump, adjusting the pump to intervene for high or low blood glucose counts, worries about 
the cannula, and watching their child answer questions about the pump. These 
experiences of learning to adapt to the pump mirrored some experiences of adapting to 
diabetes when first diagnosed: 
 
“I think had she been given the pump on diagnosis I think it would have been 
much different. You know because all the questions around diabetes would have 
happened at the start and she would have been used to it, whereas it was like we 
were diagnosed for three years and then it was like back to square one for her a 
wee bit” (Parent 1, line 458) 
 
Recalling difficult experiences on MDI helped to reframe difficulties adjusting to the pump 
in a more positive light: 
 
“It was kind of an upheaval, but we had been in such a bad place and so worried 
before with injections that it was kind of a fresh start in a way” (Parent 6, line 214) 
 
Similarly, peer support from other parents about difficulties they may encounter in the 
early days of pump therapy was identified as helpful for allowing experiences to be 
normalised: 
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“I remember one mum saying to me “you know you will want to throw the pump 
out of the window within the first week”, and I remember that- wanting to throw it 
out the window”. (Parent 4, line 289). 
 
Finding own way with the pump 
Parents spoke about the process of finding their own way with the pump, including 
determining pump roles between parents, figuring out which pump programmes and 
functions were helpful for their child, working out when is best to change their child’s 
cannula and trying out different types of cannulas to find one which suits their child.  
 
“Initially she was on silhouette cannulas and they were horrendous because they 
left dreadful marks on her tummy… so for the first while changing the cannulas 
were a nightmare because they were big needles, she was terrified of getting it 
done…. But since we moved to the mio (cannula) it’s like night and day.” (Parent 
6 line 219) 
 
A process of “trial and error” was often described until parents had adjusted to using the 
pump in a way which suited their family: 
 
“I made the mistake of changing the cannula at night and I’ll never do that again. 
Do not change the cannula after dinner because you’re setting yourself up for a 
sleepless night.” (Parent 3, line 505) 
 
Parents described a process of growing confidence where they would first get used to 
basic functions of the pump, and then challenge themselves to use more advanced pump 
features once they comfortable with the more basic functions: 
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“you’re playing about with it all the time, and initially you’re just trying to get the 
basal right, and then you start to get a bit braver, you know you play around with 
the temporary basals and things like that” (Parent 4, line 336) 
 
Different roles and responsibilities parents shared with their spouse in relation to pump 
use were often described. Parents in this study described shouldering most of the 
responsibility for managing the pump. They reported that their spouse either: struggled to 
understand the pump, lacked confidence in cannula changing, or struggled to put a needle 
in their child. Some parents stated that their spouse could take a leading role in uploading 
data from the pump on to the computer which allowed the couple to feel that they were 
sharing the responsibility of diabetes to a greater extent compared with MDI use: 
 
“Well (husband), he’s got his thing, he puts it on the computer, I hate the 
computer, so he, he’ll upload it onto the computer a couple of times a week so 
that means we can share the load of that you know because...whereas as before 
(on MDI’s) I did everything, whereas now he does that role, he feels he’s doing 
much more than he had been doing”.(Parent 1, line 705) 
 
One parent described a degree of conflict and tension related to how the couple preferred 
to use the pump: 
 
“I was really keen to tinker with it, but I think because she hadn’t been on the 
training, she was suspicious of me” (Parent 7, line 282) 
 
Support 
Support parents received for transitioning to, and managing the pump was mostly 
perceived as excellent. Parents felt that the training for starting the pump was 
comprehensive and well-timed. They felt the diabetes team were constantly available to 
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advise on queries or problems encountered: 
 
“The consultant gave us his personal email to use if we had a problem, and if he 
was working that night he would check that email, and em, we didn’t need to use 
it, but it was just knowing that he was there.” (Parent 1, line 350) 
 
“The level of support was super…. I remember a nurse phoning us at nine o’clock 
at night, you know every night for the first three or four nights, and you know they 
are phoning you from home… (Parent 4, line 421) 
 
“We could phone the diabetes ward and email them 24/7. In fact email anytime 
and (nurse on the ward) got back to us, he was absolutely brilliant” (Parent 5, line 
212) 
 
This constancy of support was important for allowing parents to grow in confidence using 
the pump: 
 
“So every day I would email and say “this is what I think”, and they would say 
“right go ahead and do that”, and then it got to the stage where I would say “so 
I’ve done....”and they would say “that’s absolutely fine, that’s exactly what we 
would have done” (Parent 7, line 298) 
 
One parent struggling with the pump felt that she would have benefitted from more 
training days specifically for parents of children who had been on the pump for around a 
year and had questions about aspects of the pump encountered during that time: 
 
“I think the problem with the pump is you do the four (training) days and there is a 
lot to learn, and you take it all in, but it’s only until afterwards that you think “oh 
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what do I do about this”..... I think they need to have more workshops for kids that 
have had diabetes and they’re on the pump for maybe a year and it is things 
they’ve identified (that are difficult)”. (Parent 2, line 617) 
 
In addition to support from the diabetes medical team, two of the mothers had requested 
psychology support for their daughters as they were aware of the emotional difficulties that 
are often associated with diabetes generally, as well as body image issues surrounding 
pump use. They felt it would be important to normalise talking to a psychologist for their 
daughters. 
 
Life on the pump 
The super-ordinate theme ‘life on the pump’ incorporates key emergent themes where 
parents reflected on the increased effort often required when using the insulin pump, the 
impact of pump use on their own emotional well-being, and their perceptions of, and 
reflections around glycaemic control using the pump. 
 
More effort 
Parents often felt that the pump required more effort than MDI, with insulin pump 
management being a more complex process with more variables to manage (cannula, 
pump batteries, pump programmes, back up MDI kit in case of pump failures etc): 
 
“It’s not as easy as people think, em I suppose if you are not going to be vigilant 
and check and change things and be on top of things, you could try a profile and 
just sit back, but we are not that type of parents (laughs), so we make changes all 
the time…(Parent 3, line 197) 
 
“Ultimately, it’s a lot more work than MDI” (Parent 3, line 713) 
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“For me it’s more difficult on the pump, for me, but not for (daughter), because 
I’ve done the cannulas, we’ve worked out the ratios, all she has to do is 
physically put it in the pump”. (Parent 1, line 173) 
 
This additional effort was often accepted, however, for the lifestyle flexibility it afforded the 
family, and in some cases improved glycaemic control: 
 
“She has a great H1BC, the consultant said it’s a fabulous, fabulous result which 
is great, but he sort of hit the nail on the head when he said “you don’t get that 
without all the effort you put in “ (Parent 6, line 5) 
 
The ability to make changes to pump programmes helped parents to feel less helpless 
when their child’s glycaemic control was poor, although adjusting the settings sometimes 
required more effort in the form of frequent basal tests and sleepless nights. One mother 
felt that the pump allowed her to feel that she was doing the best for her child, but 
recognised that striving for the best glycaemic control possible had to be balanced with 
managing anxiety associated with these targets: 
 
“You don't want to be upset about it, but get it as accurate as you possibly can, 
and the pump allows you to do that so you feel your being truer to your child, you 
know, you don't want in 20 years’  time to say “well I could have done better, but it 
was too much effort you know”. (Parent 4, line 155) 
 
Parents’ emotional well-being  
Most parents described feeling a sense of relief at being able to treat their child ‘normally’ 
on the pump. They recalled no longer having to worry about sticking to rigid ways of 
eating, they could parent their children more fairly, and had more flexibility when choosing 
to make changes to the pump, which allowed more time to meet the attention needs of 
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their other children:  
 
“I always feel like I’m throwing (non T1D child) her cereal in, you know because 
you’re not measuring it, so there is an element of (daughter with T1D) does get 
more attention… it’s hard as a mum to try to balance it all, because you need to 
do all that for (daughter with T1D).. It’s much better on the pump, because all I 
have to say to (daughter with T1D) at lunch time is “your blood sugar is 7.5, 
you’ve had 50 carbohydrates, go do your pump” and she can go and do it.” 
(Parent 1, line 651) 
 
Similarly, they perceived that they could manage poor glycaemic levels more easily: 
 
“There’s definitely less stress because whatever her bloods are doing we can fix 
it, whereas previously we couldn’t fix it, and I think that was really difficult for us. 
There was a friction because no matter what we did we couldn’t fix it” (Parent 1, 
line 698) 
 
Although generally the pump was perceived as having a positive impact on the parents’ 
well-being, times of increased anxiety included:when changing cannulas, when 
considering the potential for, or dealing with pump malfunctions, and when their child was 
unhooked from the pump for certain activities: 
 
“You’re just thinking “what if doesn’t come back soon” (T1D daughter had pump 
off whilst swimming) ...and I had to find her and say “you need to come back and 
sit for a wee bit”, and that was quite hard, that's another drawback of it, that she 
can only take it off for an hour and a half and it’s got to be that way”. (Parent 5, 
line 312) 
Only one mother described having a very difficult time with frequent pump malfunctions, 
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she reported that there did not seem to be any reason why, but often her son’s pump 
would not deliver insulin. She recalled feeling panicked and frustrated when trying to get 
support from the pump manufacturers, which was exacerbated by difficulties encountered 
with the manufacturers not understanding her Scottish accent: 
 
“So I had to phone America.... I went on the phone and I was honestly, I was 
tearing my hair out because she was struggling to understand me and I was 
struggling to understand her... the frustrating thing with insulin delivery, why 
would it three times not work, and then on the fourth it works”. (Parent 2, line 
197). 
 
It seemed that these difficulties impacted on this mother’s confidence using the pump 
which may have had a knock on impact on her willingness to try out different pump 
settings with her son. She reported that it was easier to just go back to injections during 
school holidays as her son’s activity levels would not be in keeping with what his pump 
was programmed for: 
 
“Any holidays we have now I put him back on injections because I know now 
because he’s not doing all these sports the pump is programmed for….it’s easier 
during the holidays going back to injections” (Parent 2, line 319) 
 
Another parent whose son suffered from urticaria, and therefore had experienced 
difficulties with her son scratching off his cannula, seemed to feel ashamed of admitting 
that she found the pump more stressful: 
 
“I just feel much more stressed on the pump, I do, it’s a terrible thing to admit” 
(Parent 3, line 555) 
Only one mother who had experienced difficulties with pump malfunctions reported 
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that she wanted to return to MDI use. On the whole, most parents reported that the 
pump has had a positive impact on their lives and the lives of their families: 
 
“it’s easier to say to others, “don’t worry the pump will work that out, the pump will 
work out the correction doses”, not having to do things like (correcting with MDI) 
that does take the stress out you know, and it’s easier to plan things as well” 
(Parent 4, line 217) 
 
“Without sounding dramatic, it has been life changing for us, and for (son). I 
mean it really has changed the way we live our life, it’s changed the quality of our 
lives hugely” (Parent 4, line 143) 
 
Perceptions of glycaemic control 
Opinion was split as to whether the pump improved their child’s glycaemic control. Four 
parents reported that the pump gave better control; they felt the numerous settings 
allowed more exact and tailored insulin delivery matched to the child’s needs, and 
therefore felt that their child experienced more consistent control: 
 
“She (daughter) was just tested, it was 49 her HbA1c, so that’s fantastic, that’s 
really good; they said (diabetes team) they are absolutely delighted with that, so 
that’s great” (Parent 6, line 391) 
 
“There’s a lot less highs and lows, it’s a lot more consistent, a lot more constant 
now on the pump… you can be a lot more exact with what she’s eating and what 
gets punched into the pump. (Parent 5, line 279) 
 
Three parents reported that their child’s control had either improved slightly, or had not 
changed: 
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“Most importantly don’t expect a great level, I think that’s number 1, don’t expect, 
to go from an A1C of 10 to an A1C of 5, that’s not going to happen”. (Parent 3, 
line 752) 
 
Two of these parents reported that their children had experienced ketones for the first time 
on the pump. Interestingly, one father explained that even though his son had experienced 
some of the “worst highs” on the pump, he felt the pump functions gave him more control 
to manage these incidents without having to call the diabetes team: 
 
“If he had ketones (on MDI) like he’s had on the pump we probably would have 
called the hospital... but now we just fiddle with the pump and eventually get it 
right and it comes back normal” (Parent 7, line 353) 
 
This father still felt that the pump offered the opportunity for the best glycaemic control he 
could give his child despite experiencing ketones. Most of the parents considered QoL in 
relation to glycaemic control. Parents often described feeling that good glycaemic control 
superseded any QoL benefits afforded by the pump, as anxiety regarding long term health 
complications or fatal incidents resulting from hypoglycaemia were their greatest 
concerns: 
 
“It wasn’t necessarily about what would suit (daughter with T1D) at the time; it 
was about the long term goal of keeping her as healthy as we could” (Parent 1, 
line 724) 
 
Perceived impact on their child 
In this super-ordinate theme ‘perceived impact on their child’ parents reflected on how the 
pump had afforded their child more developmentally appropriate freedoms, the challenges 
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encountered with this increased autonomy, and their perception of their child’s emotional 
well-being whilst using the pump.  
 
Developing autonomy- benefits and challenges 
Parents felt that the pump allowed their children to be ‘normal’, in that the flexibility 
afforded by the pump allowed them more independence: 
 
“As soon as she was diagnosed her social life changed because mum was 
everywhere, and  mum had to be everywhere, whereas I definitely think with the 
pump, I would have the confidence that she just had to type, you know “I’m 
having a chomp”, she just had to type 15, you know at her friend’s house and 
away she went. It gives her a lot more freedom.” (Parent1, line 527) 
 
With this developing independence came some of its own challenges. Three parents 
described situations where their children had not bolused properly, with one child 
developing ketones as a result.These parents described either having to increase the 
amount of supervision their child had for bolusing as a result of these errors, threatening 
that the pump would be removed if they mismanage, or having to spell out the long term 
complications of diabetes to teach their child about the seriousness of mismanagement: 
 
“Well we had a situation when we were away where he had ketones because he 
forgot to bolus.. , I don't know if it’s good or bad parenting or not, but I'm quite 
harsh on him when he forgets. I’ve also eh, I think it’s time now, he’s old enough 
now that we need to start laying down the line of potential long term effects are of 
Diabetes, and how crucially important it is to keep his blood sugars under 
control”(Parent 7, line 398) 
 
Struggles between feelings of relief that the pump offered more developmentally 
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appropriate freedoms for children had to be balanced with parents own anxiety regarding 
whether the pump was being used properly: 
 
“They keep telling us in here that it should be a normal conversation of “how is 
your day? What did you do, blah blah blah...” but you do get round to “did you 
bolus today?”, you can’t not ask the question because you need to know”. 
(Parent 5, line 428) 
 
“It’s very difficult, because you know, they (other adults) don’t realise how 
important it is … we’ve had (son with T1D) come back where maybe he’s been at 
a sleep over and his readings have been through the roof” (Parent 2, line 454) 
 
There appeared to be anxiety associated with being solely responsible for their child’s 
diabetes. Allowing their child more responsibility also came with its own anxieties. 
Promoting pump independence was described as a process of helping children to take 
responsibility for certain aspects of pump use, with supervision increasing if the child 
forgot to bolus, if glycaemic control was poor, or for aspects of the pump which remained 
challenging like cannula changes. 
 
Child’s emotional wellbeing 
Most parents mentioned that their children appeared to be “perkier”, “happier”, had “more 
of a spark” and were “less upset” and less “grumpy” on the pump compared with MDI: 
 
“I remember saying to my husband “ I really feel like she’s a lot happier in 
herself”, em, and I really did notice a big difference when she went onto the 
pump… the only way I could describe it was that she wasn’t as flat… a wee bit 
more of a spark, a wee bit more perky and happier”, (Parent 6, line 559) 
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One mothers wondered if herdaughter was less upset as her minds was allowed more 
distance from diabetes, without the constant reminder that came from having to inject 
throughout the day: 
 
“I think Diabetes isn’t at the front of her mind all the time, and because she was 
doing all these injections….She doesn’t get as upset on the pump as she did on 
injections. (Parent 1, line 565) 
 
One mother also wondered whether her daughter felt less anxious knowing that basal 
insulin doses protected her from low glycaemic levels. Another mother spoke about how 
heart breaking it was having her daughter explain how hard diabetes was for her, but 
expressed a sense of relief that these conversations had not occurred since her daughter 
started using the pump: 
 
“...she did say to me before.. “I wish you had diabetes mum just so you could feel 
what it feels like for one day”...... but she’s never said that since the pump, and I 
don’t know if it’s just like- well if life’s going to be like this than maybe it’s not as 
bad” (Parent 5, line 547) 
 
Particularly, parents of girls in this study reported that the visibility of the pump had been 
difficult for them and their daughters to manage, especially when other people asked 
difficult questions such as “does that keep you alive”? One mother became tearful when 
describing how difficult it was watching her daughter trying to conceal her pump: 
 
“she was looking for something to cover it up (said through tears), and I said “no 
we don’t do that, just put it over it”...I thought to myself, I can’t help her look for 
rest of her life” (Parent 6, line 323) 
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Parents helped their children manage self-consciousness associated with the visibility of 
the pump through modelling humorous responses to difficult pump related questions, and 
by finding ways to wear the pump that reduced self-consciousness. Some parents 
expressed worries about how their children would cope with wearing the pump as they 
approached adolescence which is often a time of increased self-consciousness. 
 
Discussion 
To the author’s knowledge, this study is the first qualitative study employing IPA to explore 
parents’ views of managing their children’s T1D using insulin pumps, and the impact of 
this method of insulin delivery on their QoL. To this end, parents described their 
experiences of the insulin pump across four super-ordinate themes, specifically ‘life before 
the pump’, ‘transition to the pump’, ‘life on the pump’, and the ‘perceived impact for their 
child’, which facilitated an understanding of their journey adjusting to life on the pump.  
 
A concept occurring across all themes was control, with parents describing fluctuating 
perceptions of control across their experiences managing their child’s T1D. Parents 
commonly felt that they had little control on MDI, with efforts to gain control through rigid 
ways of eating and frequent injections being described as stressful and anxiety provoking. 
Fighting to get a pump appeared to have been a practical way to try to regain some 
control over feelings of helplessness encountered on MDI. Similarly, using supports 
appeared to help parents gain control using the pump after the initial upheaval that came 
with changing to this method of insulin delivery. Although parents reported that the pump 
required more effort, the ability to make changes to pump settings again helped parents to 
feel like they could do more to control their child’s diabetes. Perceptions of control 
fluctuated, particularly during difficulties encountered with the pump, and when allowing 
their children more responsibility for managing aspects of their pump use, or to take on 
more developmentally appropriate freedoms. Models of parental uncertainty when caring 
for a child with chronic illness may be theoretically useful for conceptualising fluctuating 
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feelings of control, as illness uncertainty is associated with perceptions of control37.In 
keeping with these findings, Cohen and colleagues38proposed that triggers of heightened 
uncertainty occurred for parents around changes in therapeutic regimens, when disease 
control was poor, and with new developmental demands of the child. Similar feelings of 
fluctuating control have been emphasised by other parents using the insulin pump39. 
 
Adjusting to the pump was particularly challenging for parents. In keeping with other 
qualitative research12,30,39,40, support from the diabetes team and pump manufacturers 
helped parents to grow in confidence using the insulin pump, with support being 
particularly important for managing pump malfunctions12,30; with the necessary support in 
place, pump malfunctions can be accepted as a normal part of pump therapy12. This study 
emphasises that when a parent experiences difficulties with the pump, and does not feel 
supported in resolving these, then adjustment to the pump, and subsequent confidence 
with the pump can be impacted. Families may wish to discontinue pump therapy as a 
result. A study of pump-related adverse events reported for young people by the Food and 
Drug Administration over a 10 year period identified that a third of adverse events reported 
were as a result of pump malfunctions, and 82% of cases of insulin pump adverse events 
resulted in the young person requiring hospital care41. These figures underscore the 
importance of ensuring adequate provision of support to families using the insulin pump, 
particularly at times of pump malfunction. These findings also lend support to quantitative 
studies showing that difficulties using the pump are common reasons for discontinuing 
pump therapy42. 
 
A recent systematic review identified that freedom and flexibility were more commonly 
reported benefits of the pump by parents than glycaemic control21, and quantitative 
research has found that lifestyle flexibility and QoL was deemed more important for 
parents than improved glycaemic control43. In contrast, parents in this study stressed that 
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the potential to achieve better glycaemic control superseded any QoL benefits afforded by 
the pump, with some parents reporting that they would sacrifice flexibility afforded for good 
glycaemic control, as ultimately their child’s health was the most important concern. 
 
Parents in this study reported that the pump required more effort than MDI, but this 
additional effort in the form of programme alterations, frequent basal tests and sleepless 
nights was accepted as parents felt like they were helping their child to achieve the best 
glycaemic control they could. This is interesting, because parents reported similar 
experiences of “feeding insulin”, and sleepless nights correcting insulin on MDI but 
appeared less accepting of the effort put in using this method, as this was not rewarded 
by resulting improved glycaemic control. This finding of parents putting more work into 
insulin management with the pump because they perceive that they can do more to 
control their child’s diabetes is in keeping with recent qualitative findings44. As one mother 
pointed out in this study, efforts for optimal glycaemic control need to be balanced with 
parents managing their own anxiety associated with these targets, as studies have shown 
that behaviours such as nocturnal blood glucose monitoring may have an impact on 
parental health18 and QoL17. 
 
Generally, parents reported that the pump had a positive impact on their emotional well-
being and QoL, reporting feeling relieved that their children appeared happier; that they 
could treat their child ‘normally’ and parent fairly; and feel that their child is safer with 
basal doses of insulin being delivered on the pump. Interestingly, in addition to the 
increased effort required on the pump than MDI, parents also reported anxiety associated 
with certain aspects of pump management including: their child being unhooked from the 
pump; cannula changes; pump malfunctions and difficulties encountered watching their 
children manage self-consciousness associated with the visibility of the pump. Therefore 
there appeared to be both positive and negative aspects of pump use which impacted on 
parents’ QoL to a greater or less extent across participants. These findings help to 
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highlight the complexity in understanding perceptions of QoL for parents using the pump, 
which is reflected in the literature which has not found consistent differences between 
family functioning and psychosocial measures on MDI versus the pump20.Qualitative 
studies highlighting complexities in understanding QoL for parents using the insulin pump 
may help to support the development of more robust quantitative measures to further 
understand this aspect of pump use. 
 
Findings from the super-ordinate theme ‘perceived impact for the child’ support other 
qualitative studies where parents have noticed an improvement in their child’s mood on 
the pump compared with MDI30,45,46.Improved glycaemic control has been associated with 
improvements in cognition, behaviour and emotions9, however improvements in mood 
could also be as a result of increased developmentally appropriate freedoms afforded by 
the pump, which many parents reported in this study and throughout studies in this 
field10,12,30,46. This potential benefit of children having more independence and freedom 
on the pump, including taking some responsibility for aspects of T1D management is 
particularly important when considering psychosocial development. Erikson’s 
psychosocial theory of development47suggests that children must develop feelings of 
competence and belief in their skills in their years before adolescence (age 5-11), with 
their task during adolescence being to develop their sense of independence from their 
parents. Diabetes can impact on a child’s ability to complete these tasks successfully48 
which can result in the development of feelings of inadequacy47. Benefits of the insulin 
pump in facilitating self-management and increased separation from parents are therefore 
significant for the child’s development. 
 
Olinder and colleagues’49qualitative study attempted to generate theoretical knowledge to 
explain the transfer of responsibility for T1D self-management on the pump with 
adolescents. Findings from this study lend support to processes involved in responsibility 
sharing elucidated by Olinder et al49, with young people in this study self-managing some 
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aspects of pump use and parents increasing supervision when mismanagement occurred. 
Almost half of the parents in this study reported difficulties encountered with their children 
not bolusing properly, with one child developing ketones as a result. Research has shown 
that missed meal boluses were the main reason for suboptimal control, with more than a 
third of young people missing a bolus per week50. Pump alarms may help to reduce the 
frequency of missed boluses and support young people to self-manage their diabetes 
more accurately. Struggles for parents in this study between feeling relieved that their child 
could be more independent with the pump, and managing their own anxieties around 
relinquishing control have been emphasised in earlier research49. Health care providers 
should assess where families are in the process of parent management to adolescent 
management of diabetes and support, and facilitate the gradual sharing of responsibility 
as appropriate51. 
 
Watching children manage the visibility of their insulin pump through answering questions 
from others about the pump, or through finding clothes to cover the pump was difficult for 
parents in this study. Although some studies have shown that parents tend to overestimate 
the impact of the pump on their child’s level of self consciousness12,45, other studies have 
shown that young people can find the visibility of the pump distressing, particularly when 
encountering negative reactions from peers10.Sex differences regarding body image and 
social acceptance using the insulin pump have also been reported in other qualitative 
research52. The need for further research aimed at understanding differences between 
those who struggle with the visibility of the pump, versus those who do not has been 
identified10,52. Further research in this area of pump use may help parents to support their 
children to manage issues of self-consciousness. 
 
Strengths and Limitations 
To the author’s knowledge this study is one of the few qualitative studies exploring 
parent’s experiences of the insulin pump in the United Kingdom (UK)21, and the second of 
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its kind to be carried out in Scotland44. Findings from this study are particularly relevant 
within the Scottish context, given the increased use of insulin pumps amongst the Scottish 
paediatric population23driven by clinical guidelines11 and recent Government investment24.  
 
Use of Whittemore et al’s36four primary validity criteria; credibility, authenticity, criticality 
and integrity improved the validity of this study. Credibility refers to the assumption that 
the results reported are an accurate representation of what the parents discussed. Having 
a record of what parents deemed were important points from their interview facilitated 
constant reflection during analysis to ensure that findings emerging from the raw data 
were credible. Authenticity is concerned with ensuring that findings reported actually 
reflect the experiences of the participants. Use of a semi-structured topic guide allowed 
parents to explore topics that were salient to them, while also allowing the research 
question to be addressed, which arguably improved authenticity. Criticality refers to the 
extent to which the researcher is critical of their findings. To maintain a critical view point, 
the author searched for alternative themes in the raw data and discussed these with an 
experienced qualitative supervisor who also had access to the raw data. Attention was 
paid to divergent opinions within each theme. Finally, integrity refers to the extent that 
interpretations of raw data are truthful and not biased towards the researcher’s own 
agenda. Double coding of a transcript by an experienced qualitative researcher and use of 
a reflective diary helped to maintain integrity. 
 
In keeping with the design and analysis of this study this sample is intended to be 
homogenous, and therefore findings are not generalisable. Parents in this study were 
mostly mothers from two parent families who freely gave up their time to discuss their 
experiences parenting their children with T1D using the insulin pump. Similarly, parents 
described their experiences of parenting children between the ages of 7 to 12. Therefore 
an understanding of experiences of what it is like to parent children using the insulin pump 
at other developmental stages was not determined in this study. Consistent with the 
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qualitative literature on parents’ experiences using insulin pumps21, only one father was 
interviewed in this study, thereby findings were unintentionally largely based on mothers’ 
experiences. Further research may benefit from exploring fathers’ views of the insulin 
pump, and its impact on their QoL. Similarly, as 31% of families in Scotland are single 
parent families53, research exploring single parents’ experiences of the insulin pump may 
also be warranted. 
 
Although care was taken to highlight that the researcher was not connected to the 
diabetes team, the research did take place at a diabetes clinic, and was supervised by a 
Clinical Psychologist working within the diabetes field. These factors may have had an 
influence on what parents chose to discuss. 
 
Clinical Implications 
Findings from this study illustrating experiences transitioning to the insulin pump, and life 
thereafter on the pump may be helpful for other parents when deciding whether to start 
insulin pump therapy with their children. Similarly, these findings showing the complexity 
of QoL issues surrounding insulin pump use are useful for health care providers to 
understand when supporting families with diabetes management. Although parents in this 
study reported that they were mostly well supported caring for their child’s diabetes using 
the insulin pump, an awareness of fluctuating feelings of control parents may experience 
around different stages of pump use, whilst supporting their children to be more 
independent, may also be helpful for health care professionals to be aware of. This may 
allow support to be increased for families at times of uncertainty. Similarly, it may be 
important to explore with parents anxiety associated with striving for optimal glycaemic 
control, and the lengths parents may be going to for this control, as this may have an 
impact on parental well-being. 
 
Support is fundamental for helping parents to adjust to the pump. In addition to support 
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received from health care teams and pump manufacturers, peer support from other 
parents using the pump has been  identified as particularly helpful for normalising 
frustrations during adjustment to the pump. Parents may therefore benefit from the 
provision of a list of local diabetes peer support groups from their health care provider to 
augment support received from the health care team. Health care providers should also 
be aware that support should be increased for parents experiencing pump malfunctions. 
Parents may experience pump mistrust and dissatisfaction with the pump, impacting their 
adjustment to pump use if they do not receive adequate support at this point. This may 
lead to pump discontinuation. 
 
Research Implications 
Research into parents’ experiences caring for their child using the insulin pump at different 
developmental stages may further our understanding of their support needs. Similarly, 
research focusing on fathers’ and single parents’ experiences using the insulin pump may 
help to understand how best to support these parents using this method of insulin 
management. Quantitative research exploring some of the complex factors influencing 
parental QoL caring for a child on the insulin pump may help to determine how 
generalisable these findings are, and may allow differences to be explored across different 
populations.  
 
Conclusions 
To conclude, parents in this study were generally positive about using the insulin pump to 
care for their child with T1D, with all but one parent wishing to continue with this method of 
insulin delivery. Parents faced challenges at particular times with the pump, but with 
support they often regained control over difficult aspects of pump use.Although the insulin 
pump offered increased freedom and flexibility for families, parents felt that the insulin 
pump required more effort than MDI; this was, however, accepted because parents felt the 
insulin pump provided them with the best method of achieving good glycaemic control for 
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their child. Understanding the unique challenges parents face adjusting to caring for a 
child using an insulin pump and strategies they found helpful to overcome these 
challenges, will assist diabetes teams to implement care practices centred on the needs of 
the family. 
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Chapter 3: Advanced Practice 1- Reflective Clinical Account Abstract 
 
The perils of being too goal focused in therapy 
This reflective account describes, from a developmental perspective, my experiences of 
being too goal focused in therapy. Rolfe et al’s (2001) framework for reflexive practice was 
used to structure my reflective account which describes complex clinical cases which 
increased my awareness of being too goal focused, and factors which influence this 
tendency from the client, from within myself and from wider political and organisational 
influences on the profession. This reflective account enabled me to consider the strengths 
and weaknesses of being goal focused, and the importance of striking a balance between 
structured goal focused therapy and a clear understanding of the distress behind the 
clients goals. I conclude by considering on how these reflections have shaped my view of 
how I wish to progress post qualification as a Clinical Psychologist who is mindful of these 
issues in my own clinical work, in supervision of others, and in promoting clinical 
governance. 
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Chapter 4: Advanced Practice 2- Reflective Clinical Account Abstract 
 
“To MDT or not to MDT - that is the question”- A reflection on my experiences of 
multidisciplinary team working 
Reflective practice is a key skill for Clinical Psychologists for self and professional 
development. This reflective account describes my experiences of working within multi-
disciplinary teams (MDT). I have used Gibb’s (1988) reflective model to structure my 
reflections of an experience of MDT working that went well, and one that was more 
challenging. Within these reflections I consider factors that have helped, and hindered my 
effective contribution to MDT working, considering both my own development and wider 
systemic issues. I consider the role of the Clinical Psychologist in bringing about change 
in an MDT, and in promoting a voice for Psychology and Psychologically informed care. I 
have considered the influence of policy including the British Psychological Society policy, 
New Ways of Working for Applied Psychologists (BPS, 2007), as well as the 
Psychological Therapies Matrix (The Scottish Government, 2011) on the evolving role of 
Clinical Psychologists within MDTs. I conclude by considering ways in which I aim to 
improve my current practice within MDTs, and how I hope to develop skills for bringing 
about positive change within MDT working post qualification. 
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PubMed Central upon acceptance by the journal. The accepted version is the version that 
incorporates all amendments made during peer review, but prior to the publisher’s copy-editing and 
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To preview the terms and conditions of these open access agreements please visit the Copyright 
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Authors of research articles should disclose at the time of submission any financial arrangement 
they may have with a company whose product figures prominently in the submitted manuscript or 
with a company making a competing product.  Such information will be held in confidence while the 
paper is under review and will not influence the editorial decision, but if the article is accepted for 
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consideration for publication elsewhere, and that all human and animal studies have been 
approved by the author(s)' appropriate Institutional Review Board or the institutional committee on 
human and/or animal research and ethics of their particular country, and are so noted in the 
text.  All human investigations and procedures must be conducted according to the principles 
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Appendix 2: Search Strategy 
 
# Embase Search Strategy 
1 insulin pump/ 
2 
Insulin pump*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
3 1 or 2 
4 
experience.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] 
5 experience/ 
6 personal experience/ 
7 experience$.mp. 
8 narrative/ 
9 qualitative research/ or qualitative analysis/ 
10 patient satisfaction/ or patient attitude/ 
11 parent/ or adolescent parent/ or adoptive parent/ or divorced parent/ or father/ or 
mother/ or separated parent/ or single parent/ 
12 
(parent$ or mother$ or father$).mp. [mp=title, abstract, subject headings, heading 
word, drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword] 
13 CSII.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
14 3 or 13 
15 4 or 5 or 6 or 7 or 8 or 9 or 10 
16 14 and 15 
17 limit 16 to yr="1974 -Current" 
18 limit 17 to (child <unspecified age> or adolescent <13 to 17 years>) 
19 child.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
20 child/ 
21 adolescent/ 
22 20 or 21 
23 17 and 22 
24 18 or 23 
25 11 or 12 
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26 17 and 25 
27 24 or 26 
28 limit 27 to English language 
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Appendix 3: CASP Quality Assessment Rating Scale (CASP, 2003) and Scoring 
Criteria 
Quality Questions Yes 
 (2 
points) 
Partially 
(1 point) ಯCan’t Tellರ/ No (0 
points) 
1. Was there a clear statement of the aims of the 
research?  
HINT: Consider 
• What was the goal of the research? 
• Why it was thought important? 
• Its relevance 
   
2. Is a qualitative methodology appropriate?  
HINT: Consider 
• If the research seeks to interpret or illuminate the actions and/or 
subjective experiences of research participants  
• Is qualitative research the right methodology for addressing the 
research goal? 
   
3. Was the research design appropriate to 
address the aims of the research? 
HINT: Consider 
• If the researcher has justified the research design (e.g. have they 
discussed how they decided which method to use)? 
   
4. Was the recruitment strategy appropriate to 
the aims of the research?  
HINT: Consider 
• If the researcher has explained how the participants were selected 
• If they explained why the participants they selected were the most 
appropriatetoprovide access to the type of knowledge sought by the 
study 
• If there are any discussions around recruitment (e.g. why some 
people chose not to take part) 
   
5. Were the data collected in a way that 
addressed the research issue?  
HINT: Consider  
• If the setting for data collection was justified 
• If it is clear how data were collected (e.g. focus group, semi-
structured interview etc.) 
• If the researcher has justified the methods chosen 
• If the researcher has made the methods explicit (e.g. for interview 
method, is there an indication of how interviews were conducted, or 
did they use a topic guide)? 
• If methods were modified during the study. If so, has the researcher 
explained how and why? 
• If the form of data is clear (e.g. tape recordings, video material, 
notes etc) 
• If the researcher has discussed saturation of data 
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6. Has the relationship between researcher and 
participants been adequately considered?  
HINT: Consider 
• If the researcher critically examined their own role, potential bias 
and influence during  
(a) Formulation of the research questions 
(b) Data collection, including sample recruitment and choice of 
location 
• How the researcher responded to events during the study and 
whether they considered the implications of any changes in the 
research design 
   
7. Have ethical issues been taken into 
consideration? 
HINT: Consider 
• If there are sufficient details of how the research was explained to 
participants for the reader to assess whether ethical standards were 
maintained 
• If the researcher has discussed issues raised by the study (e.g. 
issues around informed consent or confidentiality or how they have 
handled the effects of the study on the participants during and after 
the study) 
• If approval has been sought from the ethics committee 
   
8. Was the data analysis sufficiently rigorous?  
HINT: Consider  
•If there is an in-depth description of the analysis process 
• If thematic analysis is used. If so, is it clear how the 
categories/themes were derived from the data? 
• Whether the researcher explains how the data presented were 
selected from the original sample to demonstrate the analysis process 
• If sufficient data are presented to support the findings 
• To what extent contradictory data are taken into account 
• Whether the researcher critically examined their own role, potential 
bias and influence during analysis and selection of data for 
presentation 
   
9. Is there a clear statement of findings?  
HINT: Consider 
• If the findings are explicit 
• If there is adequate discussion of the evidence both for and against 
the researchers arguments 
• If the researcher has discussed the credibility of their findings (e.g. 
triangulation, respondent validation, more than one analyst) 
• If the findings are discussed in relation to the original research 
question 
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10. How valuable is the research?  
HINT: Consider 
• If the researcher discusses the contribution the study makes to 
existing knowledge or understanding e.g. do they consider the 
findings in relation to current practice or policy? or relevant 
research-based literature? 
• If they identify new areas where research is necessary 
• If the researchers have discussed whether or how the findings can 
be transferred to other populations or considered other ways the 
research may be used 
   
Comment on bias that may have impacted on the study. 
HINT: Consider 
• Selection bias 
• Influence from the researcher 
• Contradictory themes taken into account? 
• Credibility of findings 
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Appendix 4: Assessor agreement in quality ratings 
 
Study Assessor 1- 
Quality 
score 
Assessor 
2- Quality 
score 
Area of 
disagreement 
(CASP 
Questions that 
differed) 
Agreed 
quality 
score 
Sullivan-Bolyai 
et al, 2004 
 
17 17  17 
Low et al,  
 
13 14 Q3 14 
Pay et al, 2011 
with additional 
information 
from Pay,  
2009 
 
18 18  18 
Olinder et al, 
2011 
 
14 14  14 
Alsaleh et al, 
2013 
 
14 12 Q5; Q6; Q9 13 
Alsaleh et al, 
2014 
 
13 13  13 
Fosner et al, 
2014 
 
14 14  14 
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Appendix 5: Major Research Project Proposal 
 
Title: An exploration of parents’ views of managing their children's type one diabetes with 
insulin pumps 
 
Abstract 
Background:  In 2011, the Scottish Government committed to substantially increasing the 
availability of insulin pumps across Scotland; with the aim of ensuring that a quarter of 
young Scots with type 1 Diabetes (T1D) would have access to insulin pumps by March 
2013. Research into the impact of the insulin pump on quality of life has yielded conflicting 
results, and although parents play a central role in managing their child’s diabetes, few 
studies have looked at the impact of the insulin pumps on parent quality of life.  
 
Aims: This study aims to explore the views of parents managing their children’s T1D with 
insulin pumps, and to investigate the impact of this method of insulin delivery on their 
quality of life. 
 
Method: A qualitative cross-sectional study will be carried out and analysed using 
Interpretative phenomenological analysis. Parents attending the Royal Hospital for Sick 
Children (RHSC) with a child aged 12 or younger with T1D who have used the insulin 
pump will be recruited using purposive, volunteer sampling. Semi structured interviews will 
be conducted in the RHSC. 
 
Applications: The findings of this study may be helpful for clinicians, and for parents, 
deciding whether to begin insulin pump therapy with their child. 
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Introduction 
 
Background 
Type 1 diabetes (T1D) is one of the most common chronic childhood illnesses in the UK 
(Misso et al, 2010), with increasing numbers being diagnosed each year (NHS, 2013). In 
2013, more than 28,849 people were registered as having T1D in Scotland, with the 
incidence in those below ten years of age increasing from 27 to 29 percent in 2009-2011 
(NHS, 2013). 
  
T1D is a lifelong condition of multiple aetiology, whereby pancreatic cell destruction leads 
to insulin deﬁciency, characterised by chronic hyperglycaemia. Management of T1D 
requires continued attention to a number of factors which impact on glycaemic control 
including insulin administration, blood glucose monitoring, physical activity and meal 
planning (Daneman, 2006). Complications in glycaemic control may impact the eyes, 
kidneys, nerves and cardiovascular system and in some cases may lead to coma and 
even death (Misso et al, 2010). 
 
Recommended treatment of T1D includes intensive insulin replacement therapy to 
achieve glycaemic control; this is often a challenge to achieve.  Results from the 2012 
Scottish Diabetes survey indicate that more than a third of people with T1D struggle to 
achieve good glycaemic control (NHS, 2013). 
 
Insulin pumps 
The improved development and design of insulin pumps over a number of years has 
resulted in the creation of an alternative method of insulin therapy to the more commonly 
used multiple daily injections (MDIs). Insulin pumps are small devices worn outside the 
body, which continuously deliver insulin through a thin tube or needle (cannula) inserted 
subcutaneously. The insulin can be delivered at a set rate or increased by the push of a 
button when needed, for example at meal times. It is advised that the cannula be replaced 
and repositioned every three days (NICE, 2008).  
 
A Cochrane review of 23 randomised controlled trials (including seven with participants 
below 18 years of age) comparing insulin pumps with MDIs reported that there was 
evidence to suggest that insulin pumps may result in improved glycaemic control 
compared with MDIs (Misso et al, 2010).  
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NICE Guidance for insulin pump use for T1D has stated that it should be recommended 
as a treatment option for children 12 years and above, provided that attempts to reach 
target haemoglobin A1c (HbA1c) levels with MDIs result in the person having ‘disabling 
hypoglycaemia’ or HbA1c levels have remained high (8.5% or above) with MDIs despite 
careful attempts to manage their diabetes (NICE, 2008, p.1). There were concerns over 
insufficient data on insulin pump therapy for those under 12. The guidelines therefore 
recommended the use of insulin pump therapy “as a possible treatment if treatment with 
multiple daily injections is not practical or is not considered appropriate” (NICE, 2008, p.1). 
 
In 2011, in response to the emerging evidence base in support for insulin pumps, the 
Cabinet Secretary for Health, Wellbeing and Cities Strategy announced that NHS 
Scotland will commit to substantially increasing the availability of insulin pump therapy 
across Scotland, with the aim of ensuring that a quarter of young Scots with T1D would 
have access to insulin pumps by March 2013 (The Scottish Government, 2012). The 
Scottish Government pledged funding of over two million pounds to deliver the 
aforementioned commitment (The Scottish Government, 2012). A recent Scottish 
Government CEL 4 report indicates that insulin pump use is increasing (The Scottish 
Government, 2012), with 16.1% (n=466) of those with T1D below 18 years of age using 
an insulin pump (NHS Boards, 2013). 
 
Insulin pumps and quality of life  
The majority of studies on insulin pump therapy focus on the clinical effectiveness and 
medical outcomes resulting from this method of insulin delivery. However studies have 
emerged which suggest that greater benefits may occur beyond good glycaemic control. 
For example, improved glycaemic control is associated with benefits across cognition, 
behaviour and emotions (Ambler et al, 2006). A number of clinical specialists, patient 
experts and studies have indicated that the use of insulin pumps yield a number of quality 
of life benefits, including greater flexibility, autonomy, spontaneity, socialisation, improved 
sleep, improved mood, decreased fear of hypoglycaemia and less physical burden (NICE, 
2008; Phillip et al, 2007; Whittaker, 2012).  However, a number of factors have been 
reported which may impact negatively on quality of life such as infections at the cannula 
site, pump malfunctions, the need for appropriate supervision of pump therapy in young 
children, school related issues and visibility of the pump (Klingensmith et al, 2001; Low et 
al, 2005; NICE, 2008). In 2007, Barnard and colleagues carried out a systematic review to 
synthesise the literature on the impact of insulin pumps on quality of life, and to ascertain 
whether pumps yielded quality of life benefits for people with T1D. Their findings were 
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inconclusive due to a number of poor quality studies in this field, and inconsistency in the 
assessment of quality of life (Barnard et al, 2007). 
 
The impact of the insulin pump on parenting for a child with T1D 
The task of managing T1D in young children rests almost completely on adult carers. A 
wide variety of carer burden, stress and anxiety has been reported including variability of 
food intake, monitoring activity levels, the need to be constantly accessible to other 
caregivers, strain in the relationship between the family and the child’s school, engaging in 
anxiety provoking nocturnal blood glucose monitoring, and fear of hypoglycaemia 
(Barnard et al, 2010; Monaghan et al, 2009; Muller-Godffroy, 2009; Phillip et al, 2007).  
These factors have been shown to affect both parental health and quality of life (Barnard 
et al, 2010; Monaghan et al, 2009). 
 
Some studies have suggested that insulin pumps allowed parents of children with T1D 
greater ﬂexibility, spontaneity and freedom in their lives, reduced parental stress and 
worry regarding their child’s overall care, and greater confidence and independence in 
managing their child's diabetes (Litton et al, 2002; Müller-Godeffroy et al, 2009; Phillip et 
al, 2007).  Similarly, a Scottish qualitative investigation of the effect of the insulin pump on 
young people’s quality of life found that they reported less parental burden and more 
parental support with the insulin pump compared to MDIs (Whittaker, 2012). However, a 
meta-analysis on the psychosocial impact of insulin pump therapy reported no consistent 
differences in anxiety, depression, QoL, self-esteem, and family functioning between MDIs 
and insulin pump therapy (Weissberg-Benchell et al, 2003).  
 
Gaps in the knowledge base 
On the whole, studies investigating the impact of insulin pump therapy on QoL in T1D 
yield conﬂicting results. Authors of a recent systematic review highlighted that there is 
limited qualitative data into experiences of parents caring for children with T1D using 
insulin pumps (Alsaleh et al, 2012). They identified only six studies which described the 
experiences of children and/ or their parents with insulin pumps therapy, of these studies 
the majority were carried out in the United States (US). Only two studies were carried out 
in the United Kingdom (UK), one using structured telephone interviews (Barnard et al, 
2008) and the other questionnaires (Wilson et al, 2008). Both studies failed to state the 
duration of pump therapy, and our understanding of parents’ experiences may have been 
limited by the methodologies used. This review and individual studies solely focusing on 
parents’ experiences of caring for children with T1D have highlighted the scarcity of 
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research in this area; authors in this field have concluded that further investigations of 
parent quality of life are warranted (Alsaleh et al, 2012; Monaghan et al, 2009). These 
gaps in the evidence base are particularly relevant when considering the increased use of 
insulin pumps in Scotland driven by Scottish Government investment.  
 
Aims 
This study aims to explore parents’ views of managing their children’s diabetes with 
insulin pumps compared to multiple daily injections. It is hoped that this study will provide 
insight into the impact of insulin pumps on parents’ quality of life. 
 
Objectives 
(I) To explore the views of parents managing their children’s T1D with insulin pumps 
(II) To investigate the perceived impact of the insulin pump on parents’ quality of life 
 
Methods 
 
Design 
This study will be an exploratory qualitative study and will use Interpretative 
Phenomenological Analysis (IPA). IPA aims to explore flexibly and in detail how the 
research participant makes sense of their experiences, whilst acknowledging that the 
analysis of this exploration of experience is influenced by the researcher's interpretation of 
these views (Smith & Osborn, 2003). The IPA approach has been most commonly used to 
explore experiences with illness, and an exploration of experiences of diabetes has been 
stated as being consonant with the IPA approach (Smith, 2011). 
 
Participants 
In keeping with IPA principals, a purposive, well defined homogeneous sample (Smith & 
Osborn, 2003) of parents of children with T1D attending the Glasgow Royal Hospital for 
Sick Children (RHSC) will be recruited for this study. The purpose of this qualitative study 
will not be to provide a generalisable account of experiences of managing T1D using 
insulin pumps, but to provide an in depth account of each individual's experience of their 
child’s diabetes management, whilst also allowing exploration of similarity and difference 
of experiences within the sample. 
 
A number of sample sizes for using IPA have been suggested (Smith et al., 2009; Smith & 
Osborn, 2003). This study aims to recruit a sample of eight participants which is 
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consistent with the recommendation of between four and ten participants for a 
professional doctorate (Smith et al, 2009). 
 
Consistent with developmental stages, research into children with T1D is often divided 
into age bands of 12 years or younger, and above 12 years of age (Devenney et al, 
2011). Presumably this is because a young person has not yet reached the final stage of 
cognitive development, the formal operational stage, which according to Piaget is 
necessary for abstract problem solving (Piaget, 1953). Parents will therefore play a crucial 
role in helping their children to manage their diabetes during their younger years. For this 
reason this study will focus on the experiences of parents with children aged 12 or 
younger with T1D who make use of, or have used the insulin pump. It has been 
suggested that it can take parents six weeks to nine months to feel confident using the 
insulin pump after initializing therapy (Sullivan-Bolyai et al, 2004), in order to prevent initial 
confidence issues from influencing the data, parents with more than nine months 
experience of using the pump will be included. Due to the exploratory nature of this study, 
both genders of parents will be included; this is consistent with other research in this field 
(Sullivan-Bolyai et al, 2004; Wilson, 2008). Interviews will be carried out on an individual 
basis if both parents wish to take part. 
 
Inclusion criteria 
 Has a child aged 12 or younger with a diagnosis of T1D and have used (current or  
past use) an insulin pump for at least nine months  
 Child has no additional major chronic health conditions requiring hospital 
attendance 
 Child does not have siblings with major chronic health conditions requiring hospital 
attendance  
 Fluent in English 
 Has a child attending the RHSC 
 
Recruitment procedure 
A clinician from the diabetes team in the RHSC will be invited to identify parents of 
children attending the RHSC that meet the inclusion criteria. In August 2014, the Diabetes 
team will have 99 patients that meet the study inclusion criteria.  A random sample of 25 
identified parents will be sent an information pack about the study in the first instance. 
This information pack will contain a covering letter from the diabetes team explaining why 
they are being contacted, an information sheet about the project, and a participant 
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response form (appendices 7-9).  Posters will also be put up in the waiting room of the 
Diabetes outpatient department to invite those who meet the inclusion criteria to take part 
(appendix 10). The principal researcher will contact interested participants via their 
preferred method and arrange an appointment to carry out the interview at a suitable time 
within the RHSC. Written informed consent will be gained prior to conducting the interview 
(appendix 11). Participants will be recruited until the required number of participants has 
been met, or until data saturation. 
 
Research Procedures 
An interview schedule has been developed based on the existing literature and through 
discussion with the principal researcher and supervisors (appendix 12). It will be piloted 
on the first three interviews and revisions made if necessary (pilot interviews will be 
included in the analysis). The interview schedule will guide the semi structured interviews 
which will last for approximately 30-45 minutes. Interviews will be recorded using a digital 
voice recorder and transcribed verbatim.  At the end of each interview the participant will 
be asked to summarise the main points discussed. The researcher will record these points 
on cards and then ask the participant to rank summary points in order of importance as a 
form of respondent validation. All participant identifiable data will be deleted from the 
transcripts to preserve anonymity. 
 
Settings and equipment 
Interviews will take place in a private room within the RHSC. A digital voice recorder, 
transcription equipment and access to a University of Glasgow computer will be required 
for the recording, storing and analysis of the interviews. 
 
Data analysis 
Interviews will be analysed in accordance to guidance outlined by IPA developer 
Professor Jonathan Smith (Smith, 2007). This will involve a number of readings of the 
transcripts to identify interesting or significant points raised, followed by the identification 
of emerging themes that aim to reflect the participant’s experience. Emerging themes will 
be charted to allow for connections to be made in the data within a participant’s 
experience, and between participants’ experiences. A reflective journal will be kept by the 
principal researcher throughout data analysis to facilitate the identification and 
minimisation of bias from her own viewpoint. 
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An adaptation of Kreuger and Casey's (1994, p.137) long table approach will be used to 
sort data according to IPA guidelines. This involves cutting, sorting and arranging data 
into categories on a long table. This approach will be adapted using Microsoft Word.  
Each quote in the transcript will be given a unique identifier, data will then be copied and 
pasted into groups and subgroups based on the emerging themes. Kreuger and Casey 
(1994) recommend this approach for a novice qualitative researcher rather than using 
qualitative analysis software (such as NVIVO or NUD*IST), since the long-table approach 
involves visually sorting information which often facilitates familiarity with the data, and 
specialised qualitative computer programmes may be difficult to operate. 
 
A subset of transcripts will be independently analysed by a second experienced 
researcher in order to assess inter-rater reliability. Thematic interpretations will be 
discussed and verified by an experienced researcher.  
 
Dissemination of results 
This study will be written up for: publication in a peer reviewed scientific journal; presented 
as a component of a thesis for a Doctorate in Clinical Psychology; and as an internal 
report to the Diabetes Team in the RHSC. Participants will be asked at the interview 
whether they would like to have a copy of the research findings. If they do, these will be 
sent to them when the study is complete via their preferred method of communication. 
 
Health and safety issues 
The interviews will be carried out in the RHSC during normal working hours and will 
comply with standard safety procedures. 
 
Researcher safety issues 
Procedures used in this study will be similar to those used by clinical psychologists with 
these participants, and are not normally associated with production of significant distress.  
 
Participant safety issues 
Participants will be informed that their participation in this study is voluntary; they can opt 
out at any time without this affecting the quality of care their child receives from the 
RHSC. It will be explained prior to conducting the interviews that interviews will be 
recorded and all participant identifiable data will be removed from the transcripts. An 
opportunity will be given to have any comments removed from the transcripts after the 
interview. Participants will be informed that anonymised transcripts will be securely stored 
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on a University of Glasgow password protected computer. Written consent will be 
obtained, and limits of confidentiality addressed, before commencing the interviews. The 
clinical team will be consulted if any issues of risk arise in relation to the participant’s, or 
their children. Similarly, the clinical team will be consulted if a participant is deemed to 
have psychological difficulties or experience significant distress during the interview. An 
option will be available for participants to be referred for psychological input if necessary, 
and at the end of each interview participants will be given a list of resources for additional 
support including confidential helplines. 
 
Ethical issues 
Permission to conduct the study will be sought from a Proportionate Review Research 
Ethics Committee and the local Research and Development board. Pertinent ethical 
issues which have been considered and addressed within this proposal include: obtaining 
informed consent, confidentiality procedures, anonymisation of transcripts, researcher and 
participant safety. 
 
Signed consent forms will be stored in a locked cabinet, with access limited to the 
principal researcher.  
 
Financial issues 
Costs of stationary and stamps will be reimbursed by the University of Glasgow. The 
principal researcher's travel costs will be reimbursed by the NHS. 
 
Timetable: 
January 2014:  Proposal submission to university for approval 
June 2014:   Apply for ethical approval 
August 2014:        Recruitment 
February 2015: Transcribing and coding data 
March 2015:  Analysis 
April/June 2015: Write up  
July 2015:  Submit to university 
 
Practical implications 
The results of this study will provide an understanding of what is like to parent a child with 
T1D using the insulin pump.  Additionally, this study may provide insights into the impact 
of the insulin pump on parents’ perceived quality of life and overall family functioning. To 
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date, there are few studies about parents’ experiences of using the insulin pump in the 
UK, and no studies of this nature in Scotland. Insight into the experiences of these parents 
may be helpful for others deciding whether or not to begin insulin pump therapy with their 
child, and it may provide clinicians with a greater understanding of the impact of the 
insulin pump on parenting. Findings from this study may identify areas for clinical 
intervention and may provide grounds for further research.  
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Appendix 6: Covering Letter from the Diabetes Team  
 
Women & Children’s Directorate 
GGC CHILDREN’S DIABETES SERVICE        
    
Contact Details     
     
     Secretary    
Main Switchboard  0141 201 0000     
Diabetes Team 0141 201 0331     Anne McElwaine  0141 232 1892  
Web                         www.diabetes-scotland.org/ggc  E-mail:anne.mcelwaine@ggc.scot.nhs.uk  
Date:  
 
Dear Parent 
 
I am writing to you on behalf of Dr Oonagh Duffy and colleagues Dr Liz Hunter based at the Royal 
Hospital for Sick Children, and Dr Suzy O’Connor from the University of Glasgow. This research 
team is interested in exploring parents’ views of managing their children’s type one diabetes with 
insulin pumps.    
 
The researchers have asked me to identify a random sample of parents registered with the 
Diabetes outpatient department who have a child aged 12 or under with Type 1 Diabetes who have 
used the insulin pump for nine months or more. I have not given your name and address to the 
researchers. Please read the enclosed information sheet for more detail on this project. 
 
If you are willing to take part, please pass on the participant response form with details of the best 
way to contact you to a member of the Diabetes Team. Alternatively you can contact the principal 
researcher directly (Oonagh Duffy on 075 642 61705 or o.duffy.1@research.gla.ac.uk) if you have 
any questions about this project or if you would like to take part in this study.  
 
Thank you for taking the time to consider this request. 
With best wishes, 
 
The Diabetes Outpatient Team 
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Appendix 7: Participant Information Leaflet 
 
Title: An exploration of parents’ views of managing their children’s Type 1 Diabetes 
with insulin pumps 
You are being invited to take part in a research study which will look at parent’s 
experiences of managing their child's Diabetes using the insulin pump. This research is 
being carried out by Oonagh Duffy, Trainee Clinical Psychologist (main researcher), 
together with Dr Suzy O'Connor and Dr Elizabeth Hunter, Clinical Psychologists working 
within the University of Glasgow and the Diabetes team at the Royal Hospital for Sick 
Children.  This information leaflet has been designed to let you know why this study is 
being carried out, and what it would involve for you. Key questions that you may have are 
addressed below, however please do not hesitate to contact the main researcher if 
anything seems unclear or you would like to discuss the project further.  
 
Why is this study being carried out?  
We are interested in hearing about parents' experiences of managing their child's Type 1 
Diabetes using the insulin pump. There has been very little research carried out in the UK 
on this topic. Your experiences may help the hospital to gain a more in depth 
understanding of the impact of the insulin pump on parenting, and improve the service 
they provide to families attending the Diabetes clinic. 
 
Why am I being invited to take part? 
You are being invited to take part because you have a child aged 12 or under with Type 1 
Diabetes who has used the insulin pump for a period of at least nine months. We are 
approaching a large number of people but can only interview between 8-10 people. 
 
Do I have to take part? 
No- your participation is voluntary, and deciding not to take part will not affect the care 
your child receives in any way. You can withdraw from the study at any point without 
giving a reason and without this affecting your child's care. 
 
What do I have to do? 
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You will meet with the main researcher to take part in an interview in the Royal Hospital 
for Sick Children which is expected to last approximately 35-40 minutes. This interview will 
involve discussing your experiences of managing your child's diabetes with the insulin 
pump, and will be voice recorded. 
 
Who will know I am taking part? 
The Diabetes Outpatient Department may know that you are taking part in this study if you 
return the response form to a member of this team, or you are seen attending your 
interview in the Royal Hospital for Sick Children, but the information that you provide 
would be anonymised so that no one would be able to identify what you had said. The 
main researcher would only break confidentiality if it was believed that you or someone 
else is at risk of harm. In these circumstances the appropriate people would be informed, 
but this would be discussed with you beforehand. 
 
What will happen to the information I provide? 
Your interview will be recorded using a digital voice recorder. These voice recordings will 
be typed up word for word and then destroyed. If you feel uncomfortable with any 
comment that you have said, you will be given an opportunity to review your transcripts to 
have this comment removed. You will be asked if you wish to do this, and arrangements 
will be made for this after your interview. The information collected from you will have your 
name removed and will be given a code or a fake name so that the transcripts are 
anonymous. Anonymised transcripts will be securely stored on a University of Glasgow 
password protected computer. Only the research team will have access to your 
recordings, however, information collected about you may be looked at by representatives 
of the study Sponsor (NHS Greater Glasgow and Clyde) to ensure the study is being 
conducted properly. 
 
A report analysing all of the participants’ interviews will be submitted to the University of 
Glasgow as part of a Doctorate in Clinical Psychology, and for publication in a research 
journal. Quotes of what you have said may be used in the report to illustrate key points of 
your experience, but these will be anonymous. You will be asked at the interview whether 
you would like to have a copy of the research findings. This will be sent to you (if you 
wish) when the study is complete. 
 
Are there any benefits to taking part? 
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We cannot promise that this study will directly benefit you or your child, but your views will 
help the diabetes team to gain a more in depth understanding of the impact of the insulin 
pump on parenting. This study may also help other parents when deciding whether or not 
to begin insulin pump therapy with their child. Findings from this study may also identify 
areas for further support for children with Type 1 Diabetes and their parents, and may 
contribute to the wider diabetes research literature. If you would like impartial advice about 
participating in research please refer to www.conres.co.uk. 
 
Are there any down sides to taking part? 
It is possible that part of our discussion may bring up thoughts, feelings or memories for 
you that are upsetting. You can ask to stop the interview at any point in time if you feel 
uncomfortable. If you wished, a referral could also be made for you to talk to a Clinical 
Psychologist within the Diabetes Team. 
 
What do I do if there is a problem? 
If you are unhappy about any aspect of this study then please speak to the main 
researcher who will do her best to address your concerns. If you remain unhappy, and 
wish to complain formally, then please telephone the NHS helpline on 0800 224 4888 for 
advice on how to proceed with a complaint. 
 
Who has reviewed this study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed and 
given favourable opinion by NRES Committees-North of Scotland (2).  
 
How do I take part? 
If you are interested in taking part then please complete the attached participant response 
form and pass this on to a member of the diabetes team. Alternatively please feel free to 
contact the main researcher directly by telephone (075 642 61705) or email 
(o.duffy.1@research.gla.ac.uk). The main researcher will then arrange an appointment to 
carry out the interview at a suitable time within the Royal Hospital of Sick Children. Before 
the interview begins you will be asked to sign a consent form to say that you have read 
and understood the information in this leaflet and that you wish to take part in the study.  
 
Thank you for taking the time to read through this information leaflet. 
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Dr Oonagh Duffy (BSc PhD) 
Trainee Clinical Psychologist, NHS Greater Glasgow and Clyde 
Department of Mental Health and Wellbeing, 
Gartnavel Royal Hospital, Administration Building, 
1055 Great Western Road, 
Glasgow, G12 0XH 
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Appendix 8: Participant Response Form 
 
 
If you have read the participant information leaflet for the research study entitled “an 
exploration of parent's views of managing their children's type one diabetes with 
insulin pumps” and are interested in being contacted to take part, or to discuss the study 
further, then please complete a few details and pass this onto a member of the Diabetes 
Team or contact me directly.  
 
Your name: 
Your child's name: 
Relationship to child (please circle):   Mother   Father   
Preferred contact (please circle):   Email   Telephone 
Email address:  
Telephone number: 
If you wish to be contacted by telephone, is it ok to leave a voice message if you are not 
available to take the call? (please circle):   Yes   No 
 
Thank you, I look forward to speaking with you soon. 
Yours sincerely, 
Oonagh Duffy (Trainee Clinical Psychologist) 
o.duffy.1@research.gla.ac.uk Tel: 075 642 61705 
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Appendix 9: Poster Advertising the Study 
      
 
Research exploring parents’ views of managing their children’s Type 1 
Diabetes with insulin pumps 
 
We are a team of psychologists from NHS Greater Glasgow and Clyde and 
the University of Glasgow interested in understanding parents’ experiences 
of using the insulin pump to manage their child’s diabetes. 
 
If you have a child aged 12 or younger who has used the insulin pump for at 
least 9 months and would like to be involved then please ask a member of 
the Diabetes team for more information. Alternatively you can contact me 
directly (details below). 
 
Participation would involve meeting with me to take part in an interview in 
the Royal Hospital for Sick Children which is expected to last for 35-40 
minutes. 
 
Your views will help the diabetes team to gain a more in depth 
understanding of the impact of the insulin pump on parenting. This may help 
to identify areas for further support for children with Type 1 Diabetes and 
their parents. 
 
Please do not hesitate to contact Oonagh Duffy (Principal Researcher) by 
email o.duffy.1@research.gla.ac.uk or telephone 075 642 61705for more 
information, or if you would like to take part. 
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Appendix 10: Participant Consent Form 
 
 
 
 
Participant Consent Form 
 
Title of project: An exploration of parents’ views of managing their children’s type one 
diabetes with insulin pumps. 
 
Please initial each box if you agree with the statement. 
Name of researcher: Oonagh Duffy. 
 
I have read and understood the information sheet dated 01/07/14 version 2.2 for the 
above study. I have had time to think about the information given to me. I have had the  
opportunity to get satisfactory answers to any questions that I may have had.  
 
I understand that my participation is voluntary. I am free to withdraw from this study at any 
time, without giving a reason and without my child’s medical care or legal rights being 
affected. 
 
I understand that this interview will be audio recorded but that any information that could 
identify me will be removed from the transcripts of this recording.  
 
I understand that some quotations from the interview may be used in the write up and  
future publications of the study, but that there will be no way of identifying me from these 
quotations. 
 
I understand that some of the data collected during the study may be looked at by Clinical 
Psychologists supervising the project (Dr Elizabeth Hunter and Dr Suzy O’Connor). 
 
I understand that some of the data collected during the study may be looked at by the 
study sponsor (NHS Greater Glasgow and Clyde) for purposes of audit only. 
 
I agree to take part in the above study. 
 
___________           ___________      ____________ 
  
Your name   Date   Signature 
_________             ___________        _____________ 
 
Researcher   Date   Signature 
 
 
1 copy for the participant and 1 copy for the research team
University of Glasgow, 
Department of Mental Health and 
Wellbeing, 
Gartnavel Royal Hospital, 
Administration Building, 
1055 Great Western Road, 
Glasgow, 
G12 0XH 
Tel: 075 642 61705 
o.duffy.1@research.gla.ac.uk 
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Appendix 11: Interview Schedule 
 
Participants will be informed prior to commencing the interview that there are no right or 
wrong answers. This interview schedule is intended to guide discussions; however 
discussions will not be limited to this interview schedule. 
 
Experiences of having a child with Type 1 diabetes generally: 
 
Question: Can you tell me a little of what it's like to have a child with Type 1 diabetes? 
 
Prompts:  How did you find out? 
   How did it make you feel? 
   How did it impact on your life and your family's life?  
   Have you had to make adjustments to your daily routines?  
                        What’s that been like? 
  What is most difficult? 
  Are there any positives? 
 
II) Experiences of managing child's diabetes: 
 
Question: Can you tell me what the management of your child's diabetes has been like? 
 
Prompts:  Multiple daily injections first or straight to pump? 
  What were/are injections like for you and your child? 
  How much control do you feel the injections gave? 
             How did you hear about the pump? 
                       How do you and your family find the pump? 
  What made you decide to try the pump with your child? 
  What made the clinical team decide to try the pump with your child? 
  What was the change like from injections to the pump? 
                       What support did you get for this change? Was this enough?  
           Were there any aspects of pump use which you found particularly helpful or 
difficult? 
 
III) Insulin pump and quality of life: 
Question: Can you tell me about the effect of this management change on your quality of 
life? 
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Prompts:   What’s it been like to have to change the cannula every three days? How 
has it/had it impacted on your child’s quality of life and other family member’s QoL? 
 
VI) Perception of the impact of the insulin pump on child's well-being: 
Question: How do you think the pump has/had impacted on your child's ability to cope 
with diabetes? 
 
Prompts:  What impact has it had/did it have on glycaemic control? 
  How do you think they feel/felt about wearing the pump? 
  How do you think the pump affects/affected their social life? 
  How do you think it affects/affected their emotional well-being? 
  How do you think it affects/affected their sleep? 
  How do you think it affects/affected their body image? 
  How do you think it affects/affected your child's future? 
  Does the pump stop them from doing anything they used to enjoy? 
  How is the pump managed in school? 
 
V) Perception of the pump on family functioning: 
Question: What has been/ was the impact of the pump on your family life? 
 
Prompts:    In terms of flexibility of routines? 
  Family stress? 
  Family arguments? 
  Meal planning? 
  Sense of control? 
  How are siblings coping? 
 
VI) Perception of the pump overall: 
Question: What are the advantages and disadvantages of managing your child's diabetes 
with the pump compared with injections? 
 
Prompt:  Overall, which would you recommend the pump or injections? 
   What advice would you give to a parent trying to decide which regime to 
start    their child on? 
  (if currently on pump) Do you intend to keep your child on the pump? 
  Is there anything else you would like to tell me? 
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Appendix 12: NHS GG&C Research and Development Board Approval Letter 
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Appendix 13: North of Scotland Research Ethics Committee Approval Letter 
 
   
126 
 
   
127 
 
Appendix 14: Participants’ Summary Points  
 
Parent Summary Points (ranked in order of importance) 
1  Better control on the pump- can change settings 
 Family life is much better 
 Impact on daughter- daughter struggled initially 
 Adults making choices for child to give the pump a try 
2  It’s very complicated 
 The pump is a constant reminder for son that he has diabetes 
 Disappointed by the pump 
 Ongoing training needed 
3  It’s not necessarily going to improve blood glucose levels 
 It takes a while to get used to 
 It’s not as easy as people think  
 Its more stressful for parents 
4 Better blood glucose control 
Improved QoL (both top ranked) 
Increased freedom and independence for son 
5  Better glycaemic control 
 Better emotional wellbeing 
 Positive impact on daughters social life 
6  Recommending the pump to other parents as the way forward 
 Using the supports available to educate yourself about diabetes and introducing 
child to range of supports including psychology 
Points deemed equally important 
7  The opportunity for better blood glucose control 
 Pump gives child freedom to live a  normal life 
 Parent and child need to be continuously vigilant 
